Notices of Compliance, 2023
2,620 notices issued in 2023, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| December 29, 2023 | 24 HOUR ALLERGY REMEDY | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 29, 2023 | NAT-CETIRIZINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 29, 2023 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2023 | OMNIPAQUE 240; OMNIPAQUE 300; OMNIPAQUE 350 | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 28, 2023 | VIAGRA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| December 28, 2023 | MINT-OLOPATADINE 0.2% | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2023 | TEVA-GABAPENTIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2023 | FOMEPIZOLE FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2023 | DEXRAZOXANE FOR INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| December 27, 2023 | CUTAQUIG | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2023 | WEZLANA; WEZLANA I.V. | Amgen Canada Inc | New Drug Submission (NDS) · Other |
| December 27, 2023 | LONGRANGE | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2023 | FUROSEMIDE SPECIAL | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2023 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2023 | PMS-RISPERIDONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 27, 2023 | TARO-AMLODIPINE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 27, 2023 | VIVOTIF | Bavarian Nordic As | New Drug Submission (NDS) · Admin |
| December 27, 2023 | BEQVEZ | Pfizer Canada Ulc | New Drug Submission (NDS) · Priority-NAS |
| December 22, 2023 | ALEVE BACK AND BODY PAIN; ALEVE CAPLETS; ALEVE LIQUID GELS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2023 | ZAXINE | Salix Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2023 | REACTINE ALLERGY; REACTINE ALLERGY LIQUID GELS; REACTINE FAST MELT JUNIOR; REACTINE RAPID DISSOLVE; REACTINE (10 MG); REACTINE (5 MG); REACTINE (CHILDREN'S SYRUP) | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2023 | T-LO; TIMOLOL MALEATE-EX | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2023 | ACH-IMATINIB | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2023 | NAT-TERIFLUNOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2023 | PRO-SAXAGLIPTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 22, 2023 | TEVA-TEMOZOLOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2023 | CABAZITAXEL FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2023 | AMIODARONE HYDROCHLORIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2023 | TEVA-BUSPIRONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2023 | M-DAPAGLIFLOZIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2023 | NUCYNTA IR | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2023 | ABRYSVO | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 21, 2023 | MINT-PERINDOPRIL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 21, 2023 | HALOPERIDOL INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2023 | APO-TACROLIMUS CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2023 | PHARMA-RAMIPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 20, 2023 | BIO-ANASTROZOLE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 20, 2023 | AG-AMLODIPINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 20, 2023 | SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 20, 2023 | MEZERA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2023 | ZEPOSIA | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2023 | PMS-TETRABENAZINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2023 | RIVA-LANSOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 20, 2023 | CAPRELSA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2023 | NRA-URSODIOL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 20, 2023 | CASPOFUNGIN FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 20, 2023 | COMPONENT TE-G IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2023 | JAMP-AMLODIPINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 19, 2023 | FLOMAX CR | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2023 | PANTOPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 19, 2023 | COMPONENT TE-S IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2023 | COMPONENT TE-200 IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2023 | COMPONENT TE-H IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2023 | COMPONENT TE-100 IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2023 | QUARESS VENTUS | Ecolab Co. | New Drug Submission (NDS) · Admin |
| December 19, 2023 | APO-AMITRIPTYLINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| December 19, 2023 | CEFA-LAK | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2023 | JAMP KETOROLAC | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2023 | DOCETAXEL INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2023 | GLN-DIMETHYL FUMARATE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2023 | MYCOBUTIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2023 | APO-VARENICLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2023 | RAMIPRIL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 18, 2023 | PRO-DUTASTERIDE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| December 18, 2023 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2023 | NOYADA | Ethypharm Inc | New Drug Submission (NDS) · Other |
| December 18, 2023 | MEFLOQUINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2023 | XYLASED 20 | Modern Veterinary Therapeutics Llc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 15, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2023 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2023 | TELMISARTAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 15, 2023 | DAYVIGO | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| December 15, 2023 | ATORVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 15, 2023 | M-AMLODIPINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 15, 2023 | PMS-ESTRADIOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 15, 2023 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| December 15, 2023 | LUPIN-TIOTROPIUM | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 15, 2023 | UPLIZNA | Horizon Therapeutics Ireland Dac | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 15, 2023 | GABAPENTIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 15, 2023 | LANVIS | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2023 | JAMP-MEMANTINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 15, 2023 | AURO-LEVETIRACETAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 15, 2023 | MOTRIN PLATINUM MUSCLE & BODY | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2023 | PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 14, 2023 | TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 14, 2023 | AURO-DARUNAVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 14, 2023 | APO-LANSOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 14, 2023 | CANDESARTAN CILEXETIL | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 14, 2023 | VIIBRYD | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| December 13, 2023 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2023 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2023 | BIO-QUETIAPINE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 13, 2023 | OXALIPLATIN INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 13, 2023 | APO-EXEMESTANE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2023 | TEVA-VALSARTAN/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 12, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| December 12, 2023 | OZURDEX | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2023 | LEVODEXA | Xediton Pharmaceuticals Inc. | New Drug Submission (NDS) · Other |
| December 12, 2023 | DIPRIVAN 1% | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2023 | ZYBAN | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2023 | AZITHROMYCIN FOR INJECTION, USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 12, 2023 | VORICONAZOLE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 12, 2023 | MIRAPEX | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2023 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2023 | TEMBEXA | Emergent Biodefense Operations Lansing Llc | New Drug Submission (NDS) · Other |
| December 8, 2023 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| December 8, 2023 | JAMP TICAGRELOR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 8, 2023 | MAR-MODAFINIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 8, 2023 | ZEPOSIA | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| December 8, 2023 | BRIVLERA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2023 | AMLODIPINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 8, 2023 | TEVA-TOPIRAMATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2023 | ADRIAMYCIN PFS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2023 | FML | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2023 | APO-EMTRICITABINE-TENOFOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2023 | LOKELMA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2023 | SANDOZ PERINDOPRIL ERBUMINE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2023 | JAMP DOMPERIDONE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 8, 2023 | JAMP NEBIVOLOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 8, 2023 | PRO-TOPIRAMATE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 8, 2023 | DANTRIUM CAPSULES | Endo Par Innovation Company, Llc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2023 | PMS-IBUPROFEN; PMS-IBUPROFEN (CAPLETS) | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2023 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2023 | AG-LAMOTRIGINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 7, 2023 | SANTYL | Smith & Nephew, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2023 | NRA-ESCITALOPRAM | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 7, 2023 | AZITHROMYCIN FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2023 | LEVETIRACETAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 7, 2023 | LYDERM | Taropharma, A Division Of Taro Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2023 | ACTEMRA SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2023 | TRUMENBA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2023 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2023 | ELREXFIO | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 6, 2023 | PREGABALIN | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2023 | RIVA-ROSUVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 6, 2023 | AG-LETROZOLE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 6, 2023 | CAMZYOS | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2023 | TOBI | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2023 | RIVA-PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 6, 2023 | SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 6, 2023 | AURO-AMOXICILLIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2023 | SCEMBLIX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2023 | LYDERM | Taropharma, A Division Of Taro Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2023 | VERZENIO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2023 | PMS-CYCLOSPORINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2023 | MYLAN-ELETRIPTAN | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| December 5, 2023 | DESVENLAFAXINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2023 | NRA-AMLODIPINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2023 | TRUSOPT; TRUSOPT PRESERVATIVE-FREE | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2023 | COSOPT; COSOPT PRESERVATIVE-FREE | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2023 | NIFEDIPINE | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2023 | ACAM2000 | Emergent Product Development Gaithersburg Inc. | New Drug Submission (NDS) · Other |
| December 5, 2023 | OLANZAPINE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2023 | JAMP LAMIVUDINE/ ZIDOVUDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2023 | SANDOZ LEFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2023 | ZYTRAM XL | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2023 | MAR-GABAPENTIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 5, 2023 | IMATINIB | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2023 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2023 | NUVAXOVID XBB.1.5 | Novavax Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 4, 2023 | MOXIFLOXACIN OPHTHALMIC SOLUTION | Beximco Pharmaceuticals Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | MEZAVANT | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2023 | MINT-TOPIRAMATE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | MYLAN-TOPIRAMATE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | PMS-DIMETHYL FUMARATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | CLOPIDOGREL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 1, 2023 | AMLODIPINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 1, 2023 | AG-RABEPRAZOLE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 1, 2023 | NURTEC ODT | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 1, 2023 | CETIRIZINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 1, 2023 | OXLUMO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2023 | MYLAN-SUMATRIPTAN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | AURO-VALSARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | AZITHROMYCIN; PMS-AZITHROMYCIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | OXYNEO | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2023 | TEVA-OLMESARTAN / HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | M-DIENOGEST | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 1, 2023 | ACH-RIVAROXABAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | TEVA-DUTASTERIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | TRIDURAL | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2023 | M-LATANOPROST | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 1, 2023 | NRA-RIVAROXABAN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 1, 2023 | AG-TICAGRELOR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 1, 2023 | LEUCOVORIN CALCIUM INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2023 | ACH-RIVAROXABAN | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 1, 2023 | MINT-RIVAROXABAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | NRA-RIVAROXABAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | ACH-RIVAROXABAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | ACH-RIVAROXABAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2023 | MINT-RIVAROXABAN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 30, 2023 | PROSCAR | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2023 | APO-ZIDOVUDINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2023 | TEVA-PANTOPRAZOLE MAGNESIUM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | TIGECYCLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | ACH-ROSUVASTATIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | PMS-CANDESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | APO-ABACAVIR-LAMIVUDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | AURO-LAMIVUDINE/ZIDOVUDINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | PANTOPRAZOLE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | MINT-ABACAVIR/LAMIVUDINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | PMS-ABACAVIR-LAMIVUDINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | JAMP-DOMPERIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 30, 2023 | DORZOLAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2023 | TARO-RAMIPRIL HCTZ | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | DECAPEPTYL | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2023 | LEFLUNOMIDE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 30, 2023 | AURO-VALSARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | OMNISCAN | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2023 | JAMP EPLERENONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 30, 2023 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2023 | M-LATANOPROST-TIMOLOL | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 30, 2023 | ADACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2023 | PROPECIA | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2023 | TARO-PERAMPANEL | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 30, 2023 | APO-INDOMETHACIN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2023 | CERDELGA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2023 | CANDESARTAN HCT | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 29, 2023 | NAT-LEVETIRACETAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 29, 2023 | LITFULO | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 29, 2023 | CLAVULIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2023 | MINT-LEVETIRACETAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 29, 2023 | JAMP-ASA 81 MG EC | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2023 | ACT LATANOPROST/TIMOLOL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2023 | TARO-POSACONAZOLE | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 29, 2023 | CARBOLITH | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2023 | SENSORCAINE; SENSORCAINE WITH EPINEPHRINE | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | ONTRUZANT | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | MIDAZOLAM INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2023 | VONVENDI | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | NUCALA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | VARIVAX III | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | KALYDECO | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| November 28, 2023 | TEVA-MEXILETINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2023 | M-DOXYCYCLINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 28, 2023 | PRAVASTATIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 28, 2023 | KETOROLAC TROMETHAMINE INJECTION, USP | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2023 | MYLAN-AMLODIPINE/ATORVASTATIN | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| November 28, 2023 | MELOXICAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2023 | TARO-VENLAFAXINE XR | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2023 | OXY.IR | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2023 | SENVELGO | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Other |
| November 27, 2023 | SURVANTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 27, 2023 | SANDOZ RIVASTIGMINE PATCH 10; SANDOZ RIVASTIGMINE PATCH 5 | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 25, 2023 | AURO-AZITHROMYCIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2023 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2023 | DRAXIMAGE SODIUM IODIDE I 131 CAPSULES, USP DIAGNOSTIC; DRAXIMAGE SODIUM IODIDE I 131 CAPSULES, USP THERAPEUTIC; DRAXIMAGE SODIUM IODIDE I 131 SOLUTION, USP DIAGNOSTIC; DRAXIMAGE SODIUM IODIDE I 131 SOLUTION, USP THERAPEUTIC | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2023 | MYOZYME | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2023 | APO-KETOROLAC | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2023 | APO-CITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2023 | APO-IBUPROFEN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2023 | LABETALOL HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2023 | AMIODARONE HYDROCHLORIDE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2023 | KOMBOGLYZE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2023 | PANTOPRAZOLE T | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 24, 2023 | JAMP CLINDAMYCIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 24, 2023 | AG-LETROZOLE TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 24, 2023 | ZESTRIL | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2023 | CABENUVA; VOCABRIA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2023 | TEVA-APIXABAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 23, 2023 | AG-LATANOPROST | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 23, 2023 | AMLODIPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 23, 2023 | INREBIC | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| November 23, 2023 | NAT-SITAGLIPTIN | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2023 | APO-TIAPROFENIC | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2023 | OLANZAPINE-ODT | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2023 | MYLAN-AMLODIPINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2023 | NUBEQA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2023 | PMS-OXYCODONE CR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2023 | TARO-TRAMADOL/ACET | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 22, 2023 | SANDOZ DAPAGLIFLOZIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2023 | GAMUNEX | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2023 | JAMP-VARDENAFIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2023 | MAYZENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2023 | ERTAPENEM FOR INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 21, 2023 | OXLUMO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2023 | DICLOFENAC | Pharma Stulln Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2023 | URSODIOL C | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 21, 2023 | AMIODARONE HYDROCHLORIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2023 | MINT-PAROXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2023 | MERCAPTOPURINE TABLETS USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2023 | SANDOZ VALSARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2023 | SANDOZ GLICLAZIDE MR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 21, 2023 | MICAFUNGIN SODIUM FOR INJECTION | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 20, 2023 | SIBBORAN | Trimedic Therapeutics Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 20, 2023 | MINT-IMATINIB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 20, 2023 | VENLAFAXINE XR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 20, 2023 | CLONAPAM | Bausch Health, Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 20, 2023 | TEVA-LORAZEPAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 20, 2023 | PACLITAXEL INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2023 | ZEVALIN | Auro Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| November 17, 2023 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2023 | BIO-QUETIAPINE XR | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| November 17, 2023 | MAR-TERIFLUNOMIDE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2023 | PMS-SERTRALINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2023 | AZITHROMYCIN FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2023 | INNOHEP | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2023 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2023 | AZITHROMYCIN FOR INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2023 | LUTATHERA | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2023 | BILTRICIDE | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2023 | ZERBAXA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2023 | ACCEL-DAPAGLIFLOZIN | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 17, 2023 | APO-DIVALPROEX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 17, 2023 | ZESTORETIC | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2023 | SOHONOS | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2023 | TEVA-TRIMEL; TEVA-TRIMEL DS | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 16, 2023 | BIMZELX | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2023 | PREVNAR 20 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2023 | VENLAFAXINE XR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 16, 2023 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2023 | BIO-SITAGLIPTIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| November 16, 2023 | MYLAN-LATANOPROST/TIMOLOL | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| November 16, 2023 | MYLAN-LATANOPROST | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| November 16, 2023 | ESBRIET | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2023 | FYCOMPA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2023 | XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2023 | MINT-ZOLPIDEM ODT | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 16, 2023 | JAMP PENTOXIFYLLINE SR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 16, 2023 | CEFOXITIN FOR INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2023 | JAMTEKI | JAMP Pharma Corporation | New Drug Submission (NDS) · Other |
| November 15, 2023 | TARO-ATORVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2023 | JAMP-LETROZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2023 | AG-CITALOPRAM TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 15, 2023 | PRAVASTATIN - 10; PRAVASTATIN - 20; PRAVASTATIN - 40 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2023 | JAMP-LATANOPROST/TIMOLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2023 | NOZINAN | Neuraxpharm Arzneimittel Gmbh | New Drug Submission (NDS) · Admin |
| November 15, 2023 | SIMVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2023 | PMS-TERAZOSIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2023 | JEMPERLI | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| November 15, 2023 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2023 | EPIDIOLEX | Gw Research Limited | New Drug Submission (NDS) · Other |
| November 15, 2023 | METVIX | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2023 | SANDOZ VALSARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2023 | WAYMADE-TRIENTINE | Waymade Plc | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2023 | VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2023 | ROZLYTREK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2023 | XIGDUO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2023 | VAGIFEM 10 | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2023 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2023 | SANDOZ LANSOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2023 | IPG-MODAFINIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2023 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2023 | APO-PANTOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2023 | PRONEXTICA LIQUID | Grifols Therapeutics Llc | New Drug Submission (NDS) · Other |
| November 10, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 10, 2023 | LAYLAA 21; LAYLAA 28 | Lupin Pharma Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 10, 2023 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2023 | BANZEL | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 10, 2023 | TRODELVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2023 | AG-SERTRALINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 10, 2023 | RIVA-AMLODIPINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 10, 2023 | MAR-DIMETHYL FUMARATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2023 | TEVA-AMPHETAMINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2023 | EDARBI | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2023 | SANDOZ ENTACAPONE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 10, 2023 | EDARBYCLOR | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2023 | VORICONAZOLE FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 10, 2023 | JAMP-TADALAFIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 10, 2023 | SANDOZ RIVASTIGMINE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 10, 2023 | TRUXIMA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2023 | MAR-FLUCONAZOLE-150 | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2023 | HAVRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | TWINRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | SYNFLORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | ENGERIX-B | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | CERVARIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | INFANRIX HEXA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | BOOSTRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 9, 2023 | MAR-RAMIPRIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 9, 2023 | MAR-AMLODIPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 9, 2023 | DAPTOMYCIN FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 9, 2023 | AURO-CANDESARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2023 | KETOROLAC TROMETHAMINE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2023 | RESOTRAN | Amdipharm Limited | New Drug Submission (NDS) · Labelling Only |
| November 9, 2023 | MINT-DICLOFENAC | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 8, 2023 | ASPARLAS | Servier Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 8, 2023 | OXALIPLATIN INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 8, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 8, 2023 | PRIVIGEN | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2023 | M-ATORVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 8, 2023 | RIVA-DUTASTERIDE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2023 | NRA-VARENICLINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 8, 2023 | SERTRALINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 7, 2023 | ONDANSETRON | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 7, 2023 | PERINDOPRIL ERBUMINE | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2023 | RIVASTIGMINE PATCH 10; RIVASTIGMINE PATCH 15; RIVASTIGMINE PATCH 5 | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 7, 2023 | ZORYVE | Arcutis Canada, Inc. | New Drug Submission (NDS) · Admin |
| November 7, 2023 | MAR-ROSUVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 6, 2023 | ADACEL-POLIO | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 6, 2023 | MAR-SERTRALINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 6, 2023 | LATANOPROST OPHTHALMIC SOLUTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 6, 2023 | JAMP-GABAPENTIN TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 3, 2023 | SANDOZ DIMETHYL FUMARATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2023 | APO-DICLOFENAC OPHTHALMIC | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 3, 2023 | LORAZEPAM INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 3, 2023 | PMS-TOPIRAMATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2023 | AURO-TOPIRAMATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2023 | AURO-SERTRALINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2023 | TEVA-CLOBAZAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2023 | DOPTELET | Swedish Orphan Biovitrum Ab (Publ) | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 3, 2023 | APO-TIMOP | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 3, 2023 | MINT-KETOROLAC | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2023 | PANTOPRAZOLE MAGNESIUM | Altius Healthcare Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| November 3, 2023 | JAMP-SIMVASTATIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2023 | MELOXIKARE CHEWABLE TABLETS | Felix Pharmaceuticals Pvt. Ltd. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 3, 2023 | MELOXIKARE CHEWABLE TABLETS | Felix Pharmaceuticals Pvt. Ltd. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 3, 2023 | REGIOCIT | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 2, 2023 | REKOVELLE | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2023 | IRBESARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 2, 2023 | AURO-AMOXICILLIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 2, 2023 | TEVA-OLANZAPINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 2, 2023 | PIQRAY | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2023 | MENQUADFI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 2, 2023 | MINT-AMLODIPINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2023 | JAMP KETOTIFEN OPHTHALMIC | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2023 | MOUNJARO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2023 | PERSANTINE | Glenwood Gmbh Pharmazeutische Erzeugnisse | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2023 | NUCEIVA | Evolus Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2023 | RIVAROXABAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 1, 2023 | AG-LEVETIRACETAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 1, 2023 | PRO-RIVAROXABAN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 1, 2023 | TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 1, 2023 | PMS-RIVAROXABAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 1, 2023 | TEVA-RIVAROXABAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | PMS-RIVAROXABAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | PMS-RIVAROXABAN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2023 | TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | PMS-RIVAROXABAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | PMS-RIVAROXABAN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2023 | TEVA-RIVAROXABAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2023 | TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2023 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 1, 2023 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2023 | REDDY-RIVAROXABAN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | REDDY-RIVAROXABAN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | RIVA RIVAROXABAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 1, 2023 | PMS-RIVAROXABAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 1, 2023 | REDDY-RIVAROXABAN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | REDDY-RIVAROXABAN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | REDDY-RIVAROXABAN | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2023 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | REDDY-RIVAROXABAN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2023 | APO-RIVAROXABAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 31, 2023 | METOCLOPRAMIDE INJECTION USP | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2023 | DORZOLAMIDE PF | Micro Labs Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 31, 2023 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2023 | EFFEXOR XR | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2023 | DARUNAVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 31, 2023 | KETOROLAC TROMETHAMINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2023 | REDDY-SAPROPTERIN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2023 | ISENTRESS; ISENTRESS HD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2023 | SANDOZ AZITHROMYCIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2023 | REDDY-SAPROPTERIN | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 31, 2023 | REDDY-SAPROPTERIN | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 30, 2023 | IMOVAX POLIO | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 30, 2023 | BYLVAY | Medison Pharma Canada Inc. | New Drug Submission (NDS) · Priority-NAS |
| October 30, 2023 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 30, 2023 | JAMP IPRATROPIUM HFA | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 30, 2023 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 30, 2023 | JAMP LAMOTRIGINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 30, 2023 | IPG-PANTOPRAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 30, 2023 | SANDOZ PANTOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2023 | ARANESP | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2023 | TARO-AMPHETAMINE XR | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2023 | PANENZA | Sanofi Pasteur Limited | New Drug Submission (NDS) · Other |
| October 27, 2023 | SODIUM NITROPRUSSIDE FOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 27, 2023 | RIVA-LEVETIRACETAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2023 | JAMP-DORZOLAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 27, 2023 | TEVA-SUNITINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2023 | CHILDREN'S IBUPROFEN SUSPENSION | Perrigo International, Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 27, 2023 | JUROX BUPRENORPHINE INJECTION | Jurox Pty Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 26, 2023 | OCTASA | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2023 | MINT-BACLOFEN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 26, 2023 | CLOROXPRO CLOROX ECOCLEAN DISINFECTING CLEANER | The Clorox Company of Canada Ltd. | New Drug Submission (NDS) · Other |
| October 25, 2023 | NIVESTYM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2023 | RIVA-LATANOPROST | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 25, 2023 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2023 | UPH-SILDENAFIL | Uphealth Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 25, 2023 | VIACORAM | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2023 | APO-TIZANIDINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 25, 2023 | MYLAN-ATORVASTATIN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2023 | DIAZEPAM INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2023 | DORZOLAMIDE-TIMOLOL PF | Micro Labs Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 25, 2023 | CANDESARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 25, 2023 | CARTROPHEN VET INJ.SC 100MG/ML | Biopharm Australia Pty Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 24, 2023 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 24, 2023 | AURO-MELOXICAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2023 | TERBINAFINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 24, 2023 | MINT-SERTRALINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 23, 2023 | PREGABALIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 23, 2023 | IPG-GABAPENTIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 23, 2023 | AG-PREGABALIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 23, 2023 | HEMGENIX | Csl Behring Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| October 20, 2023 | MOUNJARO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2023 | SITAGLIPTIN-METFORMIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2023 | TEVA-GEMFIBROZIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2023 | INQOVI | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2023 | LETYBO | Croma Aesthetics Canada, Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2023 | TARO-CLOMIPRAMINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2023 | TEVA-SERTRALINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2023 | MAR-METHIMAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2023 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2023 | MAR-DOMPERIDONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2023 | CANDESARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2023 | M-IRBESARTAN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2023 | RIVA-CIPROFLOXACIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2023 | PRO-MIRTAZAPINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| October 20, 2023 | APO-PERINDOPRIL/AMLODIPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2023 | TEVA-LACOSAMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2023 | KETAMINE INJECTION, BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2023 | FULVESTRANT INJECTION | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 20, 2023 | MOVAPO | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | ZIRABEV | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | APO-AMLODIPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2023 | TECARTUS | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | TARGIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | M-ROSUVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 19, 2023 | AURO-BUSPIRONE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2023 | RYBELSUS | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | ENVARSUS PA | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | ESTALIS 140/50; ESTALIS 250/50 | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | ESTRADOT 100; ESTRADOT 25; ESTRADOT 37.5; ESTRADOT 50; ESTRADOT 75 | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | RETEVMO | Loxo Oncology Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | JAMP TOFACITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2023 | MULTIHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2023 | APO-DASATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2023 | CLASTEON | Sumitomo Pharma Canada, Inc. | New Drug Submission (NDS) · Admin |
| October 18, 2023 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 18, 2023 | TPOXX | Siga Technologies, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2023 | CITALOPRAM | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 18, 2023 | CETIRIZINE HYDROCHLORIDE CAPSULES | Catalent Ontario Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2023 | VYEPTI | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2023 | LOSEC MUPS | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2023 | LOSEC | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2023 | JAMP GABAPENTIN CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2023 | THIOTEPA FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2023 | AMVUTTRA | Alnylam Netherlands B.V. | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 18, 2023 | OCTASA | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2023 | APO-TELMISARTAN-AMLODIPINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 18, 2023 | JAMP CITALOPRAM TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 17, 2023 | JAMP-CYCLOBENZAPRINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 17, 2023 | ESCITALOPRAM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 17, 2023 | PMS-LOSARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 17, 2023 | MINT-EZETIMIBE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 17, 2023 | PLENDIL | Glenwood Gmbh Pharmazeutische Erzeugnisse | New Drug Submission (NDS) · Admin |
| October 17, 2023 | MYFEMBREE | Sumitomo Pharma Switzerland Gmbh | New Drug Submission (NDS) · Other |
| October 17, 2023 | NEURONTIN | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2023 | APO-FROVATRIPTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 17, 2023 | MED-DUTASTERIDE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2023 | TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| October 16, 2023 | SANDOZ PIRFENIDONE TABLETS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2023 | AG-TELMISARTAN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 16, 2023 | AG-PRAVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 16, 2023 | AG-ZOLPIDEM ODT | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 13, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2023 | PANZYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2023 | HYRIMOZ | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2023 | EPKINLY | AbbVie Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 13, 2023 | MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2023 | APO-FLUCONAZOLE-150 | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2023 | ACH-DIMETHYL FUMARATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2023 | TOVIAZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2023 | VORICONAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2023 | TOBI PODHALER | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2023 | OMEPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 13, 2023 | IRBESARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 13, 2023 | SANDOZ PIRFENIDONE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2023 | ACT AMLODIPINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2023 | SUBLINOX | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2023 | APO-DICLOFENAC | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2023 | LUMAKRAS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2023 | RBX-ATORVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2023 | ARSENIC TRIOXIDE FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2023 | DUOKOPT | Laboratoires Théa | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2023 | LETROZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 12, 2023 | LUPIN-CELECOXIB | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2023 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2023 | MAR-CETIRIZINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 12, 2023 | DONEPEZIL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 12, 2023 | DONEPEZIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 12, 2023 | IPG-RAMIPRIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2023 | JAMP-LEVETIRACETAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 12, 2023 | APO-SULFATRIM ORAL SUSPENSION | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2023 | WILATE | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2023 | PMS-LOSARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2023 | AURO-ABACAVIR/LAMIVUDINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2023 | TEVA-PANTOPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2023 | OVIDREL | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2023 | FORXIGA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2023 | KANUMA | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2023 | PRIVIGEN | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2023 | RANOPTO | Teva Canada Limited | New Drug Submission (NDS) · Other |
| October 11, 2023 | MYLAN-LANSOPRAZOLE; MYLAN-LANSOPRAZOLE FDT | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2023 | KETOROLAC TROMETHAMINE INJECTION, USP | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2023 | IPG-AMLODIPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2023 | M-TRANYLCYPROMINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 11, 2023 | CARDALIS | Ceva Animal Health Inc | New Drug Submission (NDS) · Other |
| October 10, 2023 | M-AMOXI CLAV | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2023 | KETAMINE INJECTION, BP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2023 | PMS-PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2023 | APO-METHYLPHENIDATE; APO-METHYLPHENIDATE SR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2023 | TARO-PANTOPRAZOLE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 10, 2023 | NRA-PERINDOPRIL | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 10, 2023 | JAMP ROSUVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2023 | ORGOVYX | Sumitomo Pharma Switzerland Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 10, 2023 | ACH-HYDROXYCHLOROQUINE SULFATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | JAMP ATORVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | ACT VENLAFAXINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | BORTEZOMIB FOR INJECTION | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 6, 2023 | IPG-SERTRALINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | MYLAN-VALACYCLOVIR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | JAMP VALPROIC ACID ORAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | JAMP METHIMAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | CANESTEN COMBI 1 DAY COMFORTAB + EXTRA STRENGTH EXTERNAL CREAM | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2023 | OMEPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 6, 2023 | AMOXICILLIN/CLAV | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 6, 2023 | JAMP TICAGRELOR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2023 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2023 | M-PREGABALIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 6, 2023 | ARSENIC TRIOXIDE FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 6, 2023 | TOBRAMYCIN INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | AIMOVIG | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2023 | JAMP FROVATRIPTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2023 | MYLAN-PANTOPRAZOLE T | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2023 | ACH-AMLODIPINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2023 | SANDOZ ESOMEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2023 | PMS-ESTRADIOL 10 | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| October 5, 2023 | APO-VALPROIC ACID; APO-VALPROIC ACID ORAL SOLUTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2023 | RENFLEXIS | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2023 | SPIKEVAX BIVALENT | Moderna Biopharma Canada Corporation | New Drug Submission (NDS) · Admin |
| October 4, 2023 | SPIKEVAX | Moderna Biopharma Canada Corporation | New Drug Submission (NDS) · Admin |
| October 4, 2023 | SPIKEVAX BIVALENT (ORIGINAL/OMICRON BA.4/5) | Moderna Biopharma Canada Corporation | New Drug Submission (NDS) · Admin |
| October 4, 2023 | JAMP-PAROXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2023 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2023 | INCRELEX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2023 | ESCITALOPRAM | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2023 | DILTIAZEM T | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2023 | GLN-POSACONAZOLE | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2023 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2023 | ICLUSIG | Takeda Pharmaceuticals U.S.A., Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2023 | CUTAQUIG | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2023 | AG-PANTOPRAZOLE SODIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2023 | XEOMIN; XEOMIN COSMETIC | Merz Pharmaceuticals Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2023 | ZOPICLONE | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| October 3, 2023 | PMS-ANAGRELIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2023 | EXELON | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2023 | SIMVASTATIN-10; SIMVASTATIN-20; SIMVASTATIN-40; SIMVASTATIN-5; SIMVASTATIN-80 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 3, 2023 | AURO-AMLODIPINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2023 | SANDOZ AMLODIPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2023 | AURO-GABAPENTIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2023 | REACTINE (10 MG TABLET) | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2023 | PMS-BUPRENORPHINE-NALOXONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | SANDOZ LEVETIRACETAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | DYSPORT AESTHETIC; DYSPORT THERAPEUTIC | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2023 | AG-PAROXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2023 | DAPTOMYCIN FOR INJECTION RF | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 29, 2023 | APO-DEFERASIROX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | LAMOTRIGINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | MYLAN-ABACAVIR/LAMIVUDINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | INVEGA TRINZA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2023 | JAMP-CIPROFLOXACIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2023 | IPG-ROSUVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | DESLORATADINE ALLERGY CONTROL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | IMOVANE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2023 | VENTOLIN RESPIRATOR SOLUTION | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2023 | TEVA-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2023 | JAMP LETROZOLE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 28, 2023 | RISPERIDONE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 28, 2023 | COMIRNATY OMICRON XBB.1.5 | Biontech Manufacturing Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 28, 2023 | IMURAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2023 | INVEGA SUSTENNA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2023 | JAMP DICLOFENAC | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2023 | APO-MELOXICAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2023 | LABETALOL HYDROCHLORIDE INJECTION, USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2023 | SANDOZ ATORVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2023 | APO-TOPIRAMATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2023 | SIMPARICA | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2023 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2023 | JAMP-PRAVASTATIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 27, 2023 | APO-RASAGILINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2023 | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2023 | APO-APREMILAST TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 26, 2023 | M-LEVETIRACETAM | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 26, 2023 | AG-URSODIOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 26, 2023 | CELEBREX | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| September 26, 2023 | LYSODREN | Hra Pharma Rare Diseases | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2023 | GLN-URSODIOL | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2023 | PMS-AMLODIPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2023 | ZOPICLONE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| September 26, 2023 | DEXMEDESED | Dechra Veterinary Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2023 | BEYFORTUS | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2023 | TEVA-SITAGLIPTIN MALATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2023 | PRO-FLUCONAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 25, 2023 | ACT DILTIAZEM T | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2023 | TRANEXAMIC ACID INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2023 | SANDOZ LATANOPROST | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2023 | TEVA-MELOXICAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2023 | SANDOZ TACROLIMUS XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2023 | GLN-GABAPENTIN | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2023 | SANDOZ CYCLOSPORINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2023 | FIBRYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2023 | AA-DILTIAZ | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2023 | APO-QUINAPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2023 | EVKEEZA | Ultragenyx Pharmaceutical Inc | New Drug Submission (NDS) · Priority-NAS |
| September 22, 2023 | METOPROLOL TARTRATE INJECTION, USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2023 | LABETALOL HYDROCHLORIDE INJECTION USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 22, 2023 | JAMP DILTIAZEM T | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2023 | MYFEMBREE | Sumitomo Pharma Switzerland Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 22, 2023 | AURO-DAPAGLIFLOZIN / METFORMIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2023 | INCRUSE ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2023 | APO-TRAVOPROST-TIMOP PQ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2023 | AG-PERINDOPRIL ERBUMINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2023 | STRESNIL | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2023 | AIVLOSIN WATER SOLUBLE GRANULES | Eco Animal Health Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | TEVA-LANSOPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | TEVA-LEVETIRACETAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | TARO-FLUCONAZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | ELIGARD | Tolmar International Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | DIVALPROEX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | KANJINTI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | SANDOZ CANDESARTAN PLUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | APO-FLUCONAZOLE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | MINT-ATORVASTATIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | MAR-DARUNAVIR | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | MVASI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | AG-APIXABAN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 21, 2023 | SANDOZ OLOPATADINE 0.2% | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| September 21, 2023 | OLOPATADINE 0.2% | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| September 21, 2023 | CISPLATIN INJECTION BP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | QUILLIVANT ER CHEWABLE TABLETS; QUILLIVANT ER ORAL SUSPENSION | Kye Pharmaceuticals Inc. | New Drug Submission (NDS) · Other |
| September 21, 2023 | BIPHENTIN | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | PREVYMIS | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| September 21, 2023 | PMS-PERINDOPRIL-AMLODIPINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 21, 2023 | APO-DAPAGLIFLOZIN-METFORMIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | JALYN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | AVODART | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2023 | ERTAPENEM FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | DOM-ZOPICLONE | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2023 | IPG-DOMPERIDONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2023 | LAPELGA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2023 | CARBETOCIN INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2023 | PMS-IRON SUCROSE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2023 | MINT-VENLAFAXINE XR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2023 | NAT-OSELTAMIVIR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 19, 2023 | RYBELSUS | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2023 | VYVGART | Argenx Bv | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 19, 2023 | PREVNAR 13 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2023 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2023 | VYEPTI | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2023 | RISEDRONATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 19, 2023 | ADYNOVATE | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2023 | GIVLAARI | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2023 | DOXORUBICIN HYDROCHLORIDE INJECTION, USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 19, 2023 | EUCRISA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2023 | ATENOLOL | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| September 18, 2023 | INFLUVAC TETRA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2023 | IPG-CETIRIZINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2023 | MONOFERRIC | Pharmacosmos A | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2023 | MINT-GABAPENTIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2023 | APO-OXAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2023 | ONDANSETRON INJECTION, USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2023 | AMLODIPINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2023 | TEVA-MIRTAZAPINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 17, 2023 | TEVA-ALENDRONATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | PMS-LEVETIRACETAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP; DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | ZELDOX | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| September 15, 2023 | XULTOPHY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2023 | PMS-BUSPIRONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | TARO-TEMOZOLOMIDE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | AG-HYDROXYCHLOROQUINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 15, 2023 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2023 | APO-CLONAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| September 15, 2023 | ARNUITY ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2023 | ULTIBRO BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2023 | LEQVIO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2023 | PMS-URSODIOL C | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | SANDOZ FLUOROMETHOLONE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2023 | SANDOZ BRIMONIDINE / TIMOLOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | MINT-LATANOPROST | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2023 | SANDOZ BRIMONIDINE / TIMOLOL | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 15, 2023 | MINT-TELMISARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 14, 2023 | LACOSAMIDE INJECTION, USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 14, 2023 | APO-AZATHIOPRINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2023 | NIFEDIPINE ER | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 14, 2023 | MAR-PREGABALIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 14, 2023 | ONDANSETRON | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 14, 2023 | FLUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2023 | CIPRALEX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2023 | FLUDARA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | SANDOZ DICLOFENAC RAPIDE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | GABAPENTIN CAPSULES USP; GABAPENTIN TABLETS USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2023 | APO-DORZO-TIMOP | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2023 | GLATIRAMER ACETATE INJECTION | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| September 13, 2023 | OPDUALAG | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 13, 2023 | VABYSMO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | FLUZONE QUADRIVALENT; FLUZONE® HIGH-DOSE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | KETOROLAC | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | BRIMONIDINE P | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2023 | PRZ-BISOPROLOL | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 13, 2023 | DESOXI | Taropharma, A Division Of Taro Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2023 | TRELEGY ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | LINESSA 21; LINESSA 28 | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2023 | JAMP ONDANSETRON ODF | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 12, 2023 | FROVATRIPTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 12, 2023 | GABAPENTIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 12, 2023 | APO-CETIRIZINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2023 | ALLERGY RELIEF LIQUID GELS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2023 | AG-SILODOSIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 12, 2023 | APO-CANDESARTAN TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 12, 2023 | SPIKEVAX XBB.1.5 | Moderna Biopharma Canada Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 11, 2023 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2023 | CERVARIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2023 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2023 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2023 | REMSIMA SC | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2023 | ESPEROCT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2023 | GD-LATANOPROST/TIMOLOL | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| September 11, 2023 | REVATIO | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| September 11, 2023 | KETOROLAC TROMETHAMINE INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 11, 2023 | BORTEZOMIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 11, 2023 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 11, 2023 | TEVA-SUNITINIB | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 8, 2023 | VALPROIC ACID; VALPROIC ACID ORAL SOLUTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2023 | JAMP LEVETIRACETAM TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2023 | CYCLOBENZAPRINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 8, 2023 | APO-AMOXI SUGAR FREE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2023 | UCERIS | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2023 | PMS-SILDENAFIL R | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2023 | INTRAROSA | Cosette Pharmaceuticals, Inc. | New Drug Submission (NDS) · Admin |
| September 8, 2023 | AA-RISEDRONATE DR | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 8, 2023 | TARO-PANTOPRAZOLE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 8, 2023 | NITROGLYCERIN INJECTION USP | Mont-Pharma Inc | New Drug Submission (NDS) · Other |
| September 8, 2023 | CEFA-DRI | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2023 | APO-AMOXICILLIN-CLAVULANATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2023 | ACCEL-LEFLUNOMIDE | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2023 | BIO-PREGABALIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| September 7, 2023 | EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES; IBUPROFEN LIQUID CAPSULES | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2023 | ZOLTROX | Zoetis Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 7, 2023 | TARO-PREGABALIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2023 | NAT-OMEPRAZOLE DR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 7, 2023 | MINT-CARBAMAZEPINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 6, 2023 | REDDY-VALSARTAN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2023 | VELTASSA | Vifor Fresenius Medical Care Renal Pharma Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2023 | IMOVAX POLIO | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2023 | IMOVAX RABIES | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2023 | KOSELUGO | Alexion Pharma Gmbh | New Drug Submission (NDS) · Admin |
| September 6, 2023 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2023 | ONDANSETRON INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2023 | JAMP NINTEDANIB | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 6, 2023 | JAMP RALOXIFENE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 5, 2023 | DYSPORT AESTHETIC; DYSPORT THERAPEUTIC | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2023 | RIXIMYO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2023 | CIPROFLOXACIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 5, 2023 | MINT-LATANOPROST/TIMOLOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2023 | AA-IPRAVENT | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| September 5, 2023 | PROPRANOLOL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2023 | NAT-LANTHANUM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2023 | LAMOTRIGINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2023 | LETROZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2023 | ALLERGY RELIEF LIQUID GELS | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2023 | REYATAZ | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2023 | EPTIFIBATIDE INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2023 | FLUCONAZOLE 150 | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2023 | APO-PRAVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2023 | TARO-LANSOPRAZOLE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2023 | CLOPIDOGREL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2023 | MAR-CIPROFLOXACIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2023 | APO-OMEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2023 | APO-AZELASTINE/FLUTICASONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2023 | BRIMONIDINE | Micro Labs Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2023 | PANTOPRAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2023 | ACH-PREGABALIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 31, 2023 | FASTURTEC | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2023 | ESTROGEL | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2023 | IMJUDO | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 31, 2023 | MOUNJARO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2023 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2023 | APO-GABAPENTIN; APO-GABAPENTIN TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2023 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2023 | SANDOZ IRBESARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2023 | MED-LATANOPROST-TIMOLOL | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2023 | DETROL | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 30, 2023 | MED-LATANOPROST | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2023 | AURO-BROMFENAC | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 30, 2023 | RELPAX | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 30, 2023 | PRO-DILTIAZEM CD | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| August 30, 2023 | DILAUDID | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2023 | CLOPIDOGREL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2023 | PMS-SOLIFENACIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2023 | NAT-PREGABALIN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2023 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2023 | METOPROLOL TARTRATE INJECTION USP | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2023 | TELMISARTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 29, 2023 | FOQUEST | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2023 | APO-AMOXICILLIN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2023 | AG-OSELTAMIVIR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2023 | EUCRISA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2023 | EXTRA STRENGTH ALLERGY RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2023 | CHILDREN'S MOTRIN; CHILDREN'S MOTRIN CHEWABLE TABLETS; INFANTS' MOTRIN; JUNIOR STRENGTH MOTRIN CHEWABLE TABLETS | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2023 | APO-ARIPIPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2023 | LACOSAMIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2023 | AURO-DIMETHYL FUMARATE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2023 | BYOOVIZ | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2023 | EPTIFIBATIDE INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2023 | JAMP-CARVEDILOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2023 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2023 | PMS-DONEPEZIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2023 | JAMP-SILDENAFIL R | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2023 | SILDENAFIL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 28, 2023 | M-TICAGRELOR | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2023 | PHARMA-SIMVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 28, 2023 | HYDROMORPH CONTIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2023 | SERTRALINE-100; SERTRALINE-25; SERTRALINE-50 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 25, 2023 | MYLAN-ESCITALOPRAM | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2023 | MINT-LEUCOVORIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2023 | TEPMETKO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2023 | CARBOPLATIN INJECTION BP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2023 | PMS-MELOXICAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2023 | FLUCONAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 25, 2023 | SANDOMIGRAN DS | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2023 | TRANEXAMIC ACID INJECTION BP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2023 | JAMP ZOLPIDEM ODT | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 25, 2023 | XYLATECT 20 | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| August 24, 2023 | SANDOZ LACOSAMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2023 | OLANZAPINE ODT | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2023 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2023 | VINORELBINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2023 | PMS-LOSARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2023 | JAMP ACITRETIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 24, 2023 | JAMP ANASTROZOLE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 24, 2023 | BANAMINE | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2023 | LEVETIRACETAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2023 | AG-AMOXI CLAV SUSPENSION | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 23, 2023 | ODAN-INDOMETHACIN | Odan Laboratories Ltd. | New Drug Submission (NDS) · Admin |
| August 23, 2023 | LIBRAX | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2023 | CONTRAVE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2023 | RIVA-GABAPENTIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2023 | PMS-TELMISARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2023 | RIVA-PREGABALIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2023 | AURO-NITROFURANTOIN BID | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 22, 2023 | EUTHYROX | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2023 | ZOLOFT | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 22, 2023 | DEPO-MEDROL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2023 | SANDOZ LATANOPROST | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 21, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 21, 2023 | ACT FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 21, 2023 | APO-CILAZAPRIL/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 21, 2023 | STRENSIQ | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2023 | OCREVUS | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2023 | TYSABRI | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2023 | PROGLYCEM | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2023 | TULIEVE | Norbrook Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2023 | PERIOGARD ALCOHOL FREE | Colgate-Palmolive Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | VALACYCLOVIR | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2023 | SUSTIVA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | CADUET | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 18, 2023 | SYNTHROID | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | TEVA-PIROXICAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | AG-DONEPEZIL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2023 | VITRAKVI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | M-PERINDOPRIL ERBUMINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2023 | DIAMICRON MR | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | PEDIAPRED | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | ELIGARD | Tolmar International Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2023 | SYNCROPROST | Alivira Animal Health Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 17, 2023 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2023 | PREGABALIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 17, 2023 | RABEPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 17, 2023 | AG-VALACYCLOVIR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 17, 2023 | ONIVYDE | Ipsen Biopharmaceuticals Canada Inc | New Drug Submission (NDS) · Admin |
| August 17, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2023 | TEVA-TELMISARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2023 | EXELON PATCH | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2023 | ARSENIC TRIOXIDE FOR INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 17, 2023 | ABRAXANE FOR INJECTABLE SUSPENSION | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2023 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2023 | SANDOZ TAMSULOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2023 | SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRIC | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2023 | APO-ZOPICLONE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2023 | PREGABALIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 16, 2023 | EXTRA STRENGTH ALLERGY RELIEF; REGULAR STRENGTH ALLERGY RELIEF | Vita Health Products Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 15, 2023 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2023 | FETZIMA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2023 | ONPATTRO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2023 | MS CONTIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2023 | BRYHALI | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2023 | PANTOPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 15, 2023 | RIVA-LETROZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 15, 2023 | GD-LATANOPROST | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| August 15, 2023 | PERINDOPRIL ERBUMINE / INDAPAMIDE; PERINDOPRIL ERBUMINE / INDAPAMIDE HD | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2023 | COVERSYL | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2023 | COVERSYL PLUS; COVERSYL PLUS HD; COVERSYL PLUS LD | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2023 | SOMATULINE AUTOGEL | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2023 | TEVA-INDOMETHACIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2023 | PRZ-ABIRATERONE | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 14, 2023 | RIVA-CIPROFLOXACIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 14, 2023 | MAR-PRAVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 14, 2023 | AMOXICILLIN; AMOXICILLIN (SUGAR REDUCED) | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| August 14, 2023 | FUROSEMIDE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 14, 2023 | APO-AMOXI CLAV | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | ACH-LEVETIRACETAM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | MINT-ANASTROZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | JAMP-HYDRALAZINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | ONDANSETRON INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | ONDANSETRON OMEGA | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | XELJANZ; XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2023 | APO-AZATHIOPRINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | AURO-QUINAPRIL HCTZ | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2023 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2023 | APO-GATIFLOXACIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2023 | PRO-LORAZEPAM | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 10, 2023 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2023 | BRIDION | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2023 | ONIVYDE | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2023 | JAMP ESCITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2023 | IMVAMUNE | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2023 | MAR-RIZATRIPTAN ODT | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2023 | SOMATULINE AUTOGEL | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2023 | MONTELUKAST | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2023 | EFFEXOR XR | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 9, 2023 | PRO-ENALAPRIL - 10; PRO-ENALAPRIL - 2,5; PRO-ENALAPRIL - 20; PRO-ENALAPRIL - 5 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| August 8, 2023 | APO-SIMVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 8, 2023 | JAMP QUINAPRIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 8, 2023 | ONDANSETRON INJECTION | Andone Pharmaceutical Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2023 | DAPTOMYCIN FOR INJECTION RF | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 4, 2023 | FUROSEMIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | GRASTOFIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | AVASTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | JAMP DIGOXIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2023 | PADCEV | Seagen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | ADTRALZA | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | VICTOZA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | METOPROLOL; METOPROLOL-L | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| August 4, 2023 | HALOPERIDOL INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 4, 2023 | JAMP-URSODIOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2023 | JAMP AMOXI CLAV | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2023 | MINT-AMOXI/CLAV | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2023 | AURO-TERIFLUNOMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2023 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2023 | AREXVY | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 3, 2023 | FOSAMAX | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2023 | FOSAVANCE | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2023 | M-MONTELUKAST | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 3, 2023 | CLINOLEIC 20% | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2023 | JIVI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2023 | FLUCONAZOLE-150 | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2023 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2023 | JAMP-PREGABALIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2023 | MINT-ZOPICLONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2023 | NORVASC | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 2, 2023 | DILANTIN INFATABS; DILANTIN-125 SUSPENSION; DILANTIN-30 SUSPENSION | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 2, 2023 | LIPITOR | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| August 2, 2023 | BIO-CLOPIDOGREL | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| August 2, 2023 | FREYA 21; FREYA 28 | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2023 | APO-DEFERASIROX (TYPE J) | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2023 | SIMPARICA TRIO | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2023 | IRBESARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 2, 2023 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2023 | MINT-SPIRONOLACTONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2023 | APO-ESCITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2023 | APO-PERINDOPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2023 | SANDOZ TACROLIMUS XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2023 | AG-RASAGILINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 1, 2023 | PROCAINAMIDE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 1, 2023 | APO-METHYLPHENIDATE ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2023 | ROSUVASTATIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 31, 2023 | FUROSEMIDE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2023 | TEVA-LETROZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2023 | ELTROXIN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2023 | JAMP PREGABALIN CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2023 | MED-DORZOLAMIDE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2023 | XALATAN | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| July 31, 2023 | AQUI-S | Aqui-S New Zealand Ltd. | New Drug Submission (NDS) · Other |
| July 28, 2023 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2023 | ILUMYA | Sun Pharmaceutical Industries Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2023 | INCRELEX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2023 | OCTAPLASMA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2023 | TARO-CLOPIDOGREL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 28, 2023 | VIAGRA | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| July 28, 2023 | CLONIDINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 28, 2023 | GALAFOLD | Amicus Therapeutics Canada Inc. | New Drug Submission (NDS) · Admin |
| July 28, 2023 | ZOCOR | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2023 | APO-NAPROXEN; APO-NAPROXEN EC; APO-NAPROXEN SR | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2023 | SANDOZ SITAGLIPTIN-METFORMIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 27, 2023 | FLUCONAZOLE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 27, 2023 | TEVA-FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 27, 2023 | FOQUEST | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2023 | XIIDRA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2023 | AXBERI; AXBERI HP | Baxter Corporation | New Drug Submission (NDS) · Other |
| July 27, 2023 | APO-DILTIAZ CD | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2023 | SANDOZ TACROLIMUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 27, 2023 | IMDUR | Juno Pharmaceuticals Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2023 | REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| July 27, 2023 | NEXIUM 24HR | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2023 | NAPROXEN LIQUID GELS | Juno Otc Inc | New Drug Submission (NDS) · Other |
| July 26, 2023 | SOGROYA | Novo Nordisk Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 26, 2023 | CLINDAMYCIN IV INFUSION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2023 | AVENTYL | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2023 | LINEZOLID INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2023 | SANDOZ DONEPEZIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2023 | MIRVALA 21; MIRVALA 28 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2023 | PIQRAY | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2023 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| July 26, 2023 | TECVAYLI | Janssen Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 26, 2023 | KYPROLIS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2023 | ALHEMO | Novo Nordisk Canada Inc | New Drug Submission (NDS) · Other |
| July 26, 2023 | ANESKETIN | Eurovet Animal Health B V | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2023 | ONDANSETRON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2023 | MYLAN-LAMOTRIGINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2023 | SANDOZ VALACYCLOVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2023 | APO-LEFLUNOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2023 | AG-PERINDOPRIL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 25, 2023 | PMS-QUINAPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2023 | JAMP SOLIFENACIN SUCCINATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2023 | MAR-LETROZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2023 | MINT-FROVATRIPTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2023 | BUTRANS | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2023 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| July 24, 2023 | JAMP TERIFLUNOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2023 | LORAZEPAM INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2023 | APO-LENALIDOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2023 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2023 | XALACOM | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| July 21, 2023 | BUPIVACAINE INJECTION BP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 21, 2023 | HYDRALAZINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 21, 2023 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2023 | PREVNAR 20 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 21, 2023 | LIVMARLI | Mirum Pharmaceuticals, Inc. | New Drug Submission (NDS) · Priority-NAS |
| July 21, 2023 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2023 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2023 | FEBUXOSTAT | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 21, 2023 | METRONIDAZOLE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2023 | MEDROL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2023 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2023 | LEUCOVORIN CALCIUM INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2023 | JAMP TRETINOIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2023 | MAR-DILTIAZEM T | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2023 | TEVA-SPIRONOLACTONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2023 | RECONCILE | Pegasus Laboratories Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2023 | HULIO | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2023 | OMVOH | Eli Lilly Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 20, 2023 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2023 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2023 | JAMP PERINDOPRIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 20, 2023 | APO-BACLOFEN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2023 | ERTAPENEM FOR INJECTION | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2023 | TARO-MEDROXYPROGESTERONE INJECTION | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2023 | VOLTAREN EMULGEL; VOLTAREN EMULGEL BACK & MUSCLE PAIN; VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2023 | RIVA-SILDENAFIL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2023 | IPG-PREGABALIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2023 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2023 | TEVA-QUETIAPINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2023 | PANTOPRAZOLE SODIUM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2023 | OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2023 | OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6% | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2023 | ESAMUZE | Dr Reddys Laboratories Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2023 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2023 | SCEMBLIX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2023 | AURO-NINTEDANIB | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 19, 2023 | HYDROXYCHLOROQUINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 19, 2023 | TRODELVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 19, 2023 | JAMP VORICONAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2023 | RIVA-VALACYCLOVIR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 19, 2023 | LINEZOLID INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 19, 2023 | PRO-LEVETIRACETAM - 250; PRO-LEVETIRACETAM - 500; PRO-LEVETIRACETAM - 750 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 19, 2023 | BIPHENTIN | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2023 | CLONAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2023 | ALEMBIC-TELMISARTAN | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 18, 2023 | SOLU-MEDROL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2023 | PMS-METHOTREXATE INJECTION | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 18, 2023 | CEREZYME | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2023 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2023 | ROCURONIUM BROMIDE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 18, 2023 | ZOLEDRONIC ACID FOR INJECTION CONCENTRATE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2023 | LOXAPAC IM | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2023 | PERINDOPRIL/INDAPAMIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 17, 2023 | DOMPERIDONE-10 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| July 17, 2023 | ARSENIC TRIOXIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2023 | PMS-GABAPENTIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2023 | ANASTROZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 14, 2023 | QUATERNA | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 14, 2023 | TEVA-VENLAFAXINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2023 | JAMP HYDROXYCHLOROQUINE SULFATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2023 | METOPROLOL TARTRATE INJECTION USP | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2023 | APO-RISEDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2023 | JAMP SILODOSIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 14, 2023 | VALPROIC ACID | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2023 | BIVALIRUDIN FOR INJECTION | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 14, 2023 | RIVA-PERINDOPRIL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 14, 2023 | ONDANSETRON INJECTION USP; ONDANSETRON INJECTION USP (PRESERVATIVE FREE) | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2023 | MILRINONE LACTATE INJECTION, USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 13, 2023 | MINT-PANTOPRAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2023 | PRO-VALACYCLOVIR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 13, 2023 | M-PAROXETINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 13, 2023 | TEVA-LOSARTAN/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2023 | DUOBRII | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2023 | DOMPERIDONE | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| July 13, 2023 | LYSODREN | Hra Pharma Rare Diseases | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2023 | ANALGESIC AND MUSCLE RELAXANT | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 13, 2023 | MYL-ESOMEPRAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2023 | LAMOTRIGINE-100; LAMOTRIGINE-150; LAMOTRIGINE-25 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 13, 2023 | SANDOZ DICLOFENAC OPHTHA | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 12, 2023 | METOPROLOL TARTRATE INJECTION USP | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 12, 2023 | AMIKACIN SULFATE INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 12, 2023 | RABEPRAZOLE EC | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 12, 2023 | CELSENTRI | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2023 | MINT-LOSARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2023 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2023 | INREBIC | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2023 | ERTAPENEM FOR INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 12, 2023 | ADTRALZA | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2023 | TEVA-LEFLUNOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2023 | ADLYXINE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2023 | TEVA-AMPHETAMINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2023 | PEPCID COMPLETE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2023 | LEFLUNOMIDE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2023 | CEFTRIAXONE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2023 | TELMISARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2023 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2023 | WELIREG | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 11, 2023 | AG-LACOSAMIDE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2023 | PMS-PREGABALIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2023 | PLERIXAFOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 11, 2023 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2023 | JAMP AMOXI CLAV SUSPENSION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 11, 2023 | AG-ROSUVASTATIN CALCIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2023 | RYBREVANT | Janssen Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2023 | AG-LOSARTAN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 10, 2023 | CELEXA | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2023 | AG-CITALOPRAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 10, 2023 | RIVA-PAROXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 10, 2023 | ENALAPRILAT INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 10, 2023 | INJECTABLE ROCURONIUM BROMIDE | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 10, 2023 | TARO-ZOPICLONE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 10, 2023 | PMS-VANCOMYCIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 10, 2023 | CYTOGAM | Ki Biopharma Llc | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2023 | KETOROLAC TROMETHAMINE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2023 | M-CELECOXIB | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | FINLIUS; FINLIUS I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 7, 2023 | ALERTEC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | QUATERNA | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | PADCEV | Seagen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | MENOPUR | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | KETOROLAC TROMETHAMINE INJECTION, USP | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 7, 2023 | GARDASIL 9 | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | VAXNEUVANCE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | TD ADSORBED | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | CUROSURF | Chiesi Farmaceutici S.P.A. | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2023 | JAMP LATANOPROST | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | MEROPENEM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | APO-RISEDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | ACH-TACROLIMUS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | TARO-MELPHALAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | APO-ARIPIPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2023 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | DELSTRIGO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | ZIAGEN | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | TRIUMEQ | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | JULUCA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | JAMP TERIFLUNOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2023 | NEXPLANON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | JAMP PERINDOPRIL ERBUMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2023 | VALACYCLOVIR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 6, 2023 | INSPRA | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| July 6, 2023 | GLYCOPYRROLATE INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 6, 2023 | SMOFLIPID 20% | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | DOTAREM | Guerbet | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2023 | APO-LETROZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2023 | CRINONE | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2023 | CABENUVA; VOCABRIA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2023 | TYGACIL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2023 | SUPRANE | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2023 | FENTANYL CITRATE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2023 | MOCLOBEMIDE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2023 | AG-CITALOPRAM TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2023 | PAROXETINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 5, 2023 | GLYCOPYRROLATE INJECTION MULTIDOSE | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 5, 2023 | HEMOPHYT | Domes Pharma | New Drug Submission (NDS) · Other |
| July 5, 2023 | ESTROPLAN | Parnell Technologies Pty Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2023 | FLUMAZENIL INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2023 | JAMP APIXABAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2023 | MAYZENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2023 | APO-CLOPIDOGREL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2023 | DOCETAXEL INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2023 | TARO-DEFERASIROX | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | ACYCLOVIR SODIUM INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | TEVA-VALACYCLOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | LINEZOLID INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | CIBINQO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2023 | TOPAMAX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2023 | FLUOROHMET | University Of Ottawa Heart Institute - National Cardiac Pet Centre | New Drug Submission (NDS) · Admin |
| June 30, 2023 | LORAZEPAM SUBLINGUAL | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | APO-HYDROXYQUINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | IPG-SERTRALINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | PMS-LORAZEPAM | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2023 | JAMP REPAGLINIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | SANDOZ PREGABALIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | SANDOZ ESCITALOPRAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2023 | NAT-SUNITINIB | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2023 | FUROSEMIDE INJECTION SDZ | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2023 | ADALAT XL | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2023 | DAUNORUBICIN HYDROCHLORIDE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 29, 2023 | PROCAN SR | Searchlight Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| June 29, 2023 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2023 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2023 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2023 | SUFENTANIL CITRATE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2023 | AURO-VORICONAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2023 | BIO-FLUCONAZOLE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 28, 2023 | JAMP SPIRONOLACTONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2023 | MINT-OSELTAMIVIR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2023 | AURO-ATOMOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2023 | APO-LAMIVUDINE-ZIDOVUDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2023 | TARO-METHYLPHENIDATE ER | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2023 | TABRECTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | DOVATO | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | PRISTIQ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | SOLIQUA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | PADCEV | Seagen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | MAYZENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | ACH-TELMISARTAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2023 | SMOFLIPID 20% | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2023 | JEVTANA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2023 | AURO-PREGABALIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2023 | PMS-DEFERASIROX | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2023 | APO-SERTRALINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2023 | DAPTOMYCIN FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2023 | TEVA-ANASTROZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2023 | FENTORA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2023 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2023 | MINT-ROSUVASTATIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2023 | NAT-ERIBULIN | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 26, 2023 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2023 | ANASTROZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 26, 2023 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2023 | PLEGRIDY | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2023 | CINRYZE | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2023 | BICNU | Marcan Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2023 | LABETALOL HYDROCHLORIDE INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 26, 2023 | AUBAGIO | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2023 | BAMBEVI | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2023 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2023 | TEVA-IRBESARTAN HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2023 | AURO-IRBESARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2023 | PMS-RAMIPRIL-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2023 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2023 | PATADAY | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2023 | TISSUEBLUE | Dutch Ophthalmic Research Center International Bv | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2023 | POMALYST | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2023 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2023 | PMS-IRBESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2023 | SANDOZ IRBESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2023 | AXID | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2023 | APO-HYDROXYUREA | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2023 | AURO-AMOXICLAV | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2023 | MINT-FAMOTIDINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 22, 2023 | DAYVIGO | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2023 | JAMP-CETIRIZINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 22, 2023 | ABSORICA LD | Sun Pharmaceutical Industries Limited | New Drug Submission (NDS) · Other |
| June 22, 2023 | SANDOZ AMPHETAMINE XR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 22, 2023 | PERINDOPRIL ERBUMINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2023 | DOCETAXEL INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2023 | ACT RIZATRIPTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2023 | CEFAZOLIN FOR INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2023 | AG-PAROXETINE TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2023 | APO-SUMATRIPTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2023 | SANDOZ ENALAPRIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2023 | APO-LAMIVUDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2023 | TARO-DEFERASIROX (TYPE J) | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2023 | DOMIDINE | Eurovet Animal Health B V | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2023 | ATIPAM | Eurovet Animal Health B V | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2023 | TARO-QUINAPRIL | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 20, 2023 | APO-ONDANSETRON | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2023 | AURO-IRBESARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2023 | JAMP-BEZAFIBRATE SR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2023 | ACH-LETROZOLE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2023 | FARMAFEN | Bimeda-MTC Animal Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2023 | RETROVIR (AZT) | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2023 | SANDOZ TOBRAMYCIN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2023 | APO-PIROXICAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2023 | APO-NABILONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2023 | KADIAN | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2023 | FLUCONAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2023 | IMATINIB | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2023 | APO-DARUNAVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2023 | RIVA-QUETIAPINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2023 | NUWIQ | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2023 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2023 | GANCICLOVIR FOR INJECTION USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 16, 2023 | MAR-PERINDOPRIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2023 | LETROZOLE | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| June 16, 2023 | APO-ZIDOVUDINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2023 | ONDEXXYA | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 15, 2023 | APO-PANTOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2023 | BIO-SERTRALINE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 15, 2023 | WINLEVI | Sun Pharmaceutical Industries Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 15, 2023 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2023 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 15, 2023 | ISOVUE 200; ISOVUE 300 | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2023 | CLARITHROMYCIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 15, 2023 | TOPAMAX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2023 | AG-ALENDRONATE SODIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 15, 2023 | MYCAMINE | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2023 | SANDOZ AMOXI-CLAV TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2023 | APO-LACOSAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2023 | APO-MEDROXY; APO-MEDROXY TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2023 | EURO-CHLORHEXIDINE | Euro-Pharm International Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 15, 2023 | APO-IMATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2023 | TEVA-METFORMIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 14, 2023 | TEVA-VORICONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2023 | PMS-FLUCONAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2023 | MAR-PAROXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 14, 2023 | APO-LOSARTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2023 | DOCETAXEL INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2023 | WELIREG | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2023 | ONPATTRO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2023 | JAMP-DONEPEZIL TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2023 | APO-VALACYCLOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2023 | JAMP-ACET-TRAMADOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2023 | GENTAMICIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2023 | PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL | Panacea Biotec Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 12, 2023 | TEVA-KETOCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2023 | MELPHALAN FOR INJECTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2023 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2023 | AKEEGA | Janssen Inc. | New Drug Submission (NDS) · Other |
| June 12, 2023 | AA-LEVOCARB CR | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2023 | APRI 21; APRI 28 | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2023 | XCOPRI | Endo Ventures Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 12, 2023 | PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL | Panacea Biotec Pharma Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 9, 2023 | TOBRAMYCIN FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2023 | SUSTIVA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2023 | IPG-PRAVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2023 | IDHIFA | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2023 | SANDOZ VORICONAZOLE; VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2023 | ODAN-AMANTADINE SYRUP | Odan Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| June 9, 2023 | APO-MODAFINIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2023 | APO-AMBRISENTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2023 | SYNJARDY | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2023 | JENTADUETO | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2023 | AURO-VALGANCICLOVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2023 | SOMATULINE AUTOGEL | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2023 | XENICAL | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2023 | MINT-ABACAVIR/LAMIVUDINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2023 | APO-NORTRIPTYLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 7, 2023 | JAMP TELMISARTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2023 | SILDENAFIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 7, 2023 | DILANTIN | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| June 7, 2023 | INVEGA SUSTENNA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2023 | RIVA-SERTRALINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 6, 2023 | MENACTRA | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2023 | MINT-HYDROXYCHLOROQUINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2023 | VORICONAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2023 | SALOFALK | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2023 | SALOFALK | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2023 | SALOFALK | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2023 | MED-ANASTROZOLE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| June 6, 2023 | ZYNRELEF | Heron Therapeutics, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2023 | CELESTONE SOLUSPAN | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2023 | APO-SITAGLIPTIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2023 | BUPIVACAINE INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2023 | TARO-RABEPRAZOLE EC | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 6, 2023 | AURO-PERINDOPRIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2023 | APO-ALENDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2023 | AG-ANASTROZOLE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 6, 2023 | ACT DILTIAZEM CD | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 5, 2023 | APO-SITAGLIPTIN-METFORMIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | AZACITIDINE FOR INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | SANDOZ SAXAGLIPTIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | AMIKACIN SULFATE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | METADOL-D | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2023 | AURO-TELMISARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | APO-AMLODIPINE-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | JAMP-OMEPRAZOLE DR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | SUFENTANIL CITRATE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2023 | RIVA-ANASTROZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 3, 2023 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2023 | JAMP-ANASTROZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 2, 2023 | RISEDRONATE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 2, 2023 | RISEDRONATE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 2, 2023 | RITUXAN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2023 | RITUXAN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2023 | OSELTAMIVIR POWDER FOR ORAL SUSPENSION | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2023 | TENORMIN | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2023 | BUPROPION HCL SR | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 1, 2023 | ALEMBIC-ARIPIPRAZOLE | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 1, 2023 | NRA-ARIPIPRAZOLE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 1, 2023 | CLONIDINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2023 | SUMATRIPTAN DF | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 1, 2023 | SANDOZ TOLTERODINE LA | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2023 | VENLAFAXINE XR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2023 | PERINDOPRIL ERBUMINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2023 | AG-GLICLAZIDE MR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2023 | CITALOPRAM - 20; CITALOPRAM - 40 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2023 | NRA-TOPIRAMATE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2023 | AG-LEVETIRACETAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2023 | PMS-LETROZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2023 | MED-LETROZOLE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2023 | APO-TICAGRELOR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2023 | MINT-BETAHISTINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 1, 2023 | ASA 81 MG | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2023 | ASA | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2023 | MEN'S ROGAINE; MEN'S ROGAINE FOAM 5%; WOMEN'S ROGAINE FOAM 5% | Johnson & Johnson Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2023 | JAMP RABEPRAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | APO-RISEDRONATE DR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | FASTURTEC | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2023 | ROSUVASTATIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 31, 2023 | TOBRAMYCIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | TEVA-TRAZODONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2023 | JAMP-TIMOLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | MEROPENEM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | OSELTAMIVIR PHOSPHATE CAPSULES | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | AG-TOPIRAMATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 31, 2023 | MAR-ANASTROZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 31, 2023 | MILRINONE LACTATE INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2023 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2023 | JAMP METHIMAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | JAMP ITRACONAZOLE ORAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | APO-LAMIVUDINE HBV | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2023 | TEVA-BUSPIRONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2023 | ALERTEC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2023 | EVUSHELD | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2023 | XGEVA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2023 | BIMZELX | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2023 | APO-LAMOTRIGINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 30, 2023 | ACETYLCYSTEINE SOLUTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 30, 2023 | PIFELTRO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2023 | CETIRIZINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 30, 2023 | M-EZETIMIBE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 30, 2023 | SANDOZ POSACONAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 30, 2023 | APO-APREMILAST | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 29, 2023 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2023 | IPG-CIPROFLOXACIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2023 | DARZALEX; DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2023 | MAR-OSELTAMIVIR | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2023 | MINT-ITRACONAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2023 | ZIPRASIDONE CAPSULES | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2023 | SANDOZ DESVENLAFAXINE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 29, 2023 | ADMELOG | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2023 | DETROL LA | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| May 29, 2023 | AG-FINASTERIDE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 29, 2023 | NAT-DARUNAVIR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2023 | APO-PERINDOPRIL-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2023 | APO-MIRTAZAPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2023 | VALIUM | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| May 26, 2023 | AG-MYCOPHENOLATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 26, 2023 | NAT-LETROZOLE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2023 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2023 | CARBOPROST TROMETHAMINE INJECTION USP | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| May 26, 2023 | FIRAZYR | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2023 | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 26, 2023 | BELKYRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2023 | ACT BORTEZOMIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2023 | PMS-TRANDOLAPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2023 | ACID CONTROLLER MAXIMUM STRENGTH | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 26, 2023 | MINT-TRIMEBUTINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 25, 2023 | MABCAMPATH | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2023 | AG-RASAGILINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 25, 2023 | SANDOZ LEFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2023 | MYLAN-FLUCONAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2023 | APO-OLANZAPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2023 | APO-METOPROLOL; APO-METOPROLOL (TYPE L) | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2023 | SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE; SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE HD; SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE LD | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2023 | IRBESARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 25, 2023 | JAMP DICLOFENAC TOPICAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 25, 2023 | ONDANSETRON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2023 | DIVALPROEX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2023 | XYWAV | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · Other |
| May 25, 2023 | PERSERIS | Hls Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2023 | PRO-TOPIRAMATE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 24, 2023 | ATORVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 24, 2023 | NRA-DAPAGLIFLOZIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2023 | MAR-EZETIMIBE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 24, 2023 | FLAGYL | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| May 24, 2023 | SPINRAZA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2023 | KETALAR | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| May 24, 2023 | TRURAPI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2023 | PMS-ESCITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2023 | APO-CEFUROXIME | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2023 | WAKIX | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2023 | APO-QUETIAPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2023 | NAVANE | Searchlight Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| May 24, 2023 | BRUKINSA | Beigene Switzerland Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2023 | SANDOZ LEVETIRACETAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2023 | BRICANYL TURBUHALER | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2023 | METOPROLOL TARTRATE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | DILTIAZEM HYDROCHLORIDE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | BENLYSTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2023 | APO-ELTROMBOPAG | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | TARO-VALSARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2023 | AURO-METHOTREXATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | PMS-PERINDOPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | SANDOZ TELMISARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | APO-ELTROMBOPAG | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2023 | APO-ELTROMBOPAG | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 19, 2023 | KIVEXA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2023 | RUKOBIA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2023 | OXALIPLATIN INJECTION USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 19, 2023 | ORENCIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2023 | IOPIDINE | Essential Pharma Switzerland Gmbh | New Drug Submission (NDS) · Admin |
| May 19, 2023 | APO-TOFACITINIB | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 19, 2023 | BIO-CELECOXIB | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 19, 2023 | BIO-ZOPICLONE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 19, 2023 | RIVA-BRIMONIDINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 18, 2023 | TECFIDERA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2023 | ZYTRAM XL | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2023 | ZEMAIRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2023 | SANDOZ CANDESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 18, 2023 | PMS-PERINDOPRIL-INDAPAMIDE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2023 | JAMP POMALIDOMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2023 | VAXCHORA | Emergent Travel Health Inc. | New Drug Submission (NDS) · Other |
| May 18, 2023 | JAMP RASAGILINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 18, 2023 | APO-TRIAMCINOLONE AQ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 18, 2023 | AURIMIC | Vetviva Richter Gmbh | Abbreviated New Drug Submission (ANDS) · Admin |
| May 18, 2023 | RIFEN | Vetviva Richter Gmbh | Abbreviated New Drug Submission (ANDS) · Admin |
| May 18, 2023 | BUPAQ | Vetviva Richter Gmbh | Abbreviated New Drug Submission (ANDS) · Admin |
| May 18, 2023 | AG-EZETIMIBE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 18, 2023 | SPIKEVAX BIVALENT ORIGINAL / OMICRON BA.4/5 | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2023 | NOVAMOXIN; NOVAMOXIN (SUGAR REDUCED) | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2023 | SIGNIFOR | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2023 | TEVA-IPRATROPIUM STERINEBS | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2023 | THYROGEN | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2023 | DOM-CELECOXIB | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 16, 2023 | TEVA-PERINDOPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2023 | LEUCOVORIN CALCIUM INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2023 | APO-DAPAGLIFLOZIN-METFORMIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2023 | LOSARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 16, 2023 | AG-TRAZODONE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2023 | APO-ROSUVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2023 | MINT-ONDANSETRON ODT | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2023 | APO-ENALAPRIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2023 | AURO-DAPAGLIFLOZIN / METFORMIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2023 | GLN-DAPAGLIFLOZIN | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2023 | APO-DAPAGLIFLOZIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2023 | M-DAPAGLIFLOZIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2023 | GLN-DAPAGLIFLOZIN | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2023 | PRO-DAPAGLIFLOZIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2023 | AURO-DAPAGLIFLOZIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2023 | APO-DAPAGLIFLOZIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2023 | BRAVECTO ONE | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2023 | BRAVECTO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2023 | OGIVRI | Biosimilar Collaborations Ireland Limited | New Drug Submission (NDS) · Admin |
| May 15, 2023 | HULIO | Biosimilar Collaborations Ireland Limited | New Drug Submission (NDS) · Admin |
| May 15, 2023 | FULPHILA | Biosimilar Collaborations Ireland Limited | New Drug Submission (NDS) · Admin |
| May 15, 2023 | ABEVMY | Biosimilar Collaborations Ireland Limited | New Drug Submission (NDS) · Admin |
| May 15, 2023 | ENALAPRIL MALEATE /HCTZ | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2023 | METHACHOLINE OMEGA | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2023 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2023 | SANDOZ DAPAGLIFLOZIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2023 | AG-DAPAGLIFLOZIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 15, 2023 | JAMP-EZETIMIBE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 15, 2023 | AG-FLUOXETINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 15, 2023 | PMS-OXYCODONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2023 | SANDOZ VENLAFAXINE XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2023 | TEVA-DAPAGLIFLOZIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2023 | LOSARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 15, 2023 | TARO-DAPAGLIFLOZIN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2023 | RIVA-DAPAGLIFLOZIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2023 | SANDOZ DAPAGLIFLOZIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2023 | JAMP DAPAGLIFLOZIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2023 | PMS-DAPAGLIFLOZIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2023 | SANDOZ DAPAGLIFLOZIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2023 | NAT-DAPAGLIFLOZIN | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2023 | RIVA-DAPAGLIFLOZIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 12, 2023 | APO-OXCARBAZEPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2023 | APO-CEFUROXIME | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2023 | AURO-PIRFENIDONE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 12, 2023 | TARO-CANDESARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2023 | AG-METFORMIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 12, 2023 | OXLUMO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2023 | PERGOVERIS | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2023 | JAMP VALACYCLOVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2023 | XELJANZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2023 | ONAKTA | Avir Pharma Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 12, 2023 | RENVELA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2023 | DIACETYLMORPHINE HYDROCHLORIDE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2023 | AG-PAROXETINE TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 11, 2023 | NAT-BENDAMUSTINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | KIRSTY | Biocon Sdn.Bhd | New Drug Submission (NDS) · Admin |
| May 11, 2023 | AMIODARONE HYDROCHLORIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | ZOFRAN ODT | Sandoz Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| May 11, 2023 | SERTRALINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 11, 2023 | TEVA-EXEMESTANE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 11, 2023 | SEMGLEE | Biocon Sdn.Bhd | New Drug Submission (NDS) · Admin |
| May 11, 2023 | MARCAINE SPINAL; MARCAINE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | MARCAINE E | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | LYRICA | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| May 11, 2023 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | TEVA-PERINDOPRIL/INDAPAMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | PMS-VALACYCLOVIR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | GD-SIROLIMUS | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | FULPHILA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | JAMP-LACOSAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | BRAVECTO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | APO-OLMESARTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | APO-MYCOPHENOLATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | NEXVIAZYME | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | VITRECTO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | ADACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2023 | PMS-MONTELUKAST; PMS-MONTELUKAST FC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2023 | ALLERGY RELIEF; EXTRA STRENGTH ALLERGY RELIEF | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 10, 2023 | APO-LORAZEPAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2023 | SELEXID | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2023 | OXALIPLATIN | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2023 | RIVA-CLOPIDOGREL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2023 | DARUNAVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2023 | RABEPRAZOLE EC | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2023 | APO-AMPHETAMINE XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2023 | RIVA-CLOPIDOGREL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 9, 2023 | ELAVIL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2023 | IPG-PAROXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2023 | ZOLOFT | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2023 | RIVA LEUCOVORIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2023 | TEVA-ESCITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2023 | MINT-BUSPIRONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| May 9, 2023 | JAMP OSELTAMIVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2023 | AURO-VALACYCLOVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2023 | M-DORZOLAMIDE-TIMOLOL | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2023 | OMVYENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 8, 2023 | HYOSCINE BUTYLBROMIDE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2023 | SANDOZ LEVOFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2023 | SANDOZ LURASIDONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2023 | AG-CELECOXIB | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 8, 2023 | APO-LEVETIRACETAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2023 | ERAXIS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2023 | AURO-ROSUVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2023 | TEVA-SERTRALINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2023 | MOTRIN LIQUID GELS 200 MG; MOTRIN LIQUID GELS 400 MG | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2023 | SUPEUDOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2023 | MAR-CETIRIZINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2023 | PMS-QUETIAPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2023 | NEUPOGEN | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2023 | ZADITEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2023 | IBSRELA | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2023 | ACT-HIB | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2023 | ACT DEXTROAMPHETAMINE SR | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2023 | HYDRALAZINE HYDROCHLORIDE INJECTION, USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2023 | NEURONTIN | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| May 5, 2023 | IMCIVREE | Rhythm Pharmaceuticals, Inc | New Drug Submission (NDS) · Priority-NAS |
| May 4, 2023 | EPIRUBICIN HYDROCHLORIDE INJECTION | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2023 | MODAFINIL TABLETS | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2023 | HYDROMORPHONE HYDROCHLORIDE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2023 | NUCYNTA EXTENDED-RELEASE | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2023 | VERAPAMIL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2023 | ALDURAZYME | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2023 | MOZOBIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2023 | SIMPONI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2023 | APO-BROMFENAC | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 4, 2023 | M-DARUNAVIR | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 4, 2023 | LEMTRADA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | MIFEGYMISO | Linepharma International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | ONPATTRO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | COMBIVIR | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | 3TC | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | RIVA-CYCLOBENZAPRINE | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 3, 2023 | SILDENAFIL | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| May 3, 2023 | TEVA-FROVATRIPTAN | Endo Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 3, 2023 | HYDRALAZINE HYDROCHLORIDE INJECTION, USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 3, 2023 | ADDNUTRIV | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | EPURIS | Cipher Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | VYALEV | AbbVie Corporation | New Drug Submission (NDS) · Other |
| May 3, 2023 | NAT-LENALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2023 | MYLAN-ZIPRASIDONE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2023 | AG-CLOPIDOGREL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 3, 2023 | REDDY-LENALIDOMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2023 | HYDRALAZINE HYDROCHLORIDE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2023 | JAMP PAROXETINE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2023 | CEFTAZIDIME FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2023 | ANAFRANIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2023 | TOPIRAMATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 3, 2023 | SERTRALINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 3, 2023 | ROSUVASTATIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 2, 2023 | FLUCONAZOLE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2023 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2023 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2023 | PANZYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2023 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2023 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| May 1, 2023 | HYDROMORPHONE HYDROCHLORIDE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2023 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2023 | AG TELMISARTAN-HCT | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2023 | ANASTROZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2023 | ZENALPHA | Dechra Veterinary Products Inc. | New Drug Submission (NDS) · Other |
| April 28, 2023 | QUVIVIQ | Idorsia Pharmaceuticals Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 28, 2023 | KANUMA | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2023 | ZORYVE | Arcutis Biotherapeutics, Inc | New Drug Submission (NDS) · Other |
| April 28, 2023 | TARO-LENALIDOMIDE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2023 | IMATINIB | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 28, 2023 | VERQUVO | Bayer Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 27, 2023 | PMS-IRBESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2023 | MED-VORICONAZOLE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2023 | ZITHROMAX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2023 | AG-HYDROXYCHLOROQUINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 27, 2023 | PMS-QUINAPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2023 | DICLOFENAC-50 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2023 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2023 | AG-AMOXICILLIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 26, 2023 | ESCITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 26, 2023 | APO-TRAVOPROST-TIMOLOL PQ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2023 | SANDOZ VALACYCLOVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2023 | ETOMIDATE INJECTION, USP | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| April 26, 2023 | THIOTEPA FOR INJECTION, BP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 26, 2023 | FASENRA AND FASENRA PEN | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2023 | ROSUVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 25, 2023 | PMSC-VANCOMYCIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 25, 2023 | PANTOPRAZOLE-20; PANTOPRAZOLE-40 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 25, 2023 | APO-PROPAFENONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 25, 2023 | TREMFYA; TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2023 | APO-VALPROIC ACID; APO-VALPROIC ACID ORAL SOLUTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 25, 2023 | MINT-FINASTERIDE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 25, 2023 | ABEVMY | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2023 | CLAVULIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2023 | RIVA-ESCITALOPRAM | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 24, 2023 | NRA-CELECOXIB | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 24, 2023 | MOTRIN 200 MG; MOTRIN 300 MG; MOTRIN 400 MG | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2023 | AMBISOME | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2023 | APO-IMATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2023 | TARO-IMATINIB | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2023 | NAT-IMATINIB | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2023 | TARO-IMATINIB | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 24, 2023 | NAT-IMATINIB | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| April 23, 2023 | APO-IMATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2023 | JAMP DUTASTERIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 21, 2023 | MELPHALAN FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 21, 2023 | ALLERGY RELIEF; EXTRA STRENGTH ALLERGY RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2023 | RIVA-DORZOLAMIDE/TIMOLOL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 21, 2023 | ASMANEX TWISTHALER | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2023 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 21, 2023 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2023 | SERTRALINE | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| April 20, 2023 | XANAX; XANAX TS | BGP Pharma ULC | New Drug Submission (NDS) · Admin |
| April 20, 2023 | APO-TACROLIMUS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 20, 2023 | JAMP-TOPIRAMATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 20, 2023 | PRO-ZOLPIDEM ODT | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| April 20, 2023 | TEVA-TERIPARATIDE INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 20, 2023 | PRO-CLONAZEPAM | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| April 20, 2023 | XEOMIN COSMETIC | Merz Pharmaceuticals Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2023 | FAMOTIDINE | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| April 19, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2023 | VYEPTI | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2023 | XIGDUO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2023 | TEVA-RISEDRONATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2023 | MINT-LOSARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2023 | BEYFORTUS | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 18, 2023 | VESANOID | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2023 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2023 | INTELLI-DESVENLAFAXINE | Intellipharmaceutics Corp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 18, 2023 | XALKORI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2023 | BICILLIN L-A | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2023 | FINLIUS; FINLIUS I.V. | Janssen Inc. | New Drug Submission (NDS) · Labelling Only |
| April 18, 2023 | CATHFLO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2023 | IMMUNINE VH | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2023 | JAMP AMIODARONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 18, 2023 | ALFACALCIDOL CAPSULES | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 18, 2023 | APO-DOMPERIDONE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2023 | JAMP KETOROLAC | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 17, 2023 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21; DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28 | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2023 | APO-CLARITHROMYCIN; APO-CLARITHROMYCIN XL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2023 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | BREZTRI AEROSPHERE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | BIKTARVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | FABRAZYME | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | PMS-METHYLPHENIDATE CR | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 14, 2023 | PHARMA-LACOSAMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 14, 2023 | PRO-FLUCONAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 14, 2023 | JAMP DULOXETINE CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 14, 2023 | TAPAZOLE | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | BRIVLERA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | PMS-RABEPRAZOLE EC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2023 | SANDOZ MOXIFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2023 | VYVANSE | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | TORADOL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2023 | ASA DAILY LOW DOSE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 13, 2023 | AG-TICAGRELOR | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 13, 2023 | IRINOTECAN FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2023 | GRANISETRON HYDROCHLORIDE INJECTION | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2023 | JAMP TICAGRELOR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 13, 2023 | PEDIACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2023 | NRA-CITALOPRAM | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 13, 2023 | ERTAPENEM FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 13, 2023 | DULOXETINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 13, 2023 | SLYND | Duchesnay Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2023 | FERRLECIT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2023 | MINT-CLOPIDOGREL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 12, 2023 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2023 | JAMP RASAGILINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2023 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2023 | GANCICLOVIR FOR INJECTION | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 12, 2023 | TEVA-DILTIAZEM HCL ER | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 12, 2023 | ACT METHYLPHENIDATE ER | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2023 | ZINECARD | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2023 | VOLTAREN OPHTHA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2023 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2023 | ACH-TERIFLUNOMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2023 | APO-BRIMONIDINE-TIMOP | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2023 | JAMP BRIMONIDINE/TIMOLOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 11, 2023 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2023 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2023 | ORKAMBI | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2023 | TAGAMET PREVENT | Medtech Products, Inc. | New Drug Submission (NDS) · Admin |
| April 6, 2023 | NORTRIPTYLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2023 | CLINDAMYCIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2023 | RIVA SITAGLIPTIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 6, 2023 | DORZOLAMIDE AND TIMOLOL EYE DROPS BP | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2023 | FOSRENOL | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2023 | TARO-DICLOFENAC | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2023 | BALVERSA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2023 | ABEVMY | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2023 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 5, 2023 | LOCAMETZ | Advanced Accelerator Applications Usa, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 5, 2023 | MYLAN-HYDROXYUREA | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP; DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 5, 2023 | JAMP-FINASTERIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2023 | APO-SILDENAFIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2023 | SUPEMTEK | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | TOPIRAMATE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 4, 2023 | BUSULFAN FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 4, 2023 | BETASERON | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | GLYXAMBI | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | RIVA-RISEDRONATE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 4, 2023 | PALYNZIQ | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | MINT-TRAMADOL/ACET | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 4, 2023 | AA-CLOZAPINE | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | TORADOL IM | Atnahs Pharma Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2023 | ACT-HIB | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 3, 2023 | ENTOCORT ENEMA | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 3, 2023 | SANDOZ DILTIAZEM T | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2023 | MINT-IRBESARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2023 | ACT CLOPIDOGREL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2023 | TARO-IRBESARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2023 | ACH-OSELTAMIVIR PHOSPHATE | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 3, 2023 | SANDOZ LINEZOLID | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2023 | TEVA-IRBESARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2023 | MINT-TIZANIDINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 2, 2023 | REVLIMID | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2023 | DEXILANT | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2023 | PANTOLOC | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2023 | TECTA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2023 | RYDAPT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2023 | LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2023 | CYPROTERONE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2023 | JAMP MODAFINIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2023 | TEVA-CILAZAPRIL/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2023 | PMS-DEFERASIROX (TYPE J) | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2023 | TARO-CLOBETASOL SHAMPOO | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2023 | REDDY-SITAGLIPTIN | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 31, 2023 | PMS-CANDESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2023 | MINT-MEXILETINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 31, 2023 | PRO-AAS EC | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Other |
| March 30, 2023 | COVIFENZ | Medicago Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2023 | OXALIPLATIN INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 30, 2023 | BORTEZOMIB FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 30, 2023 | TADALAFIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 30, 2023 | FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2023 | AG-TOPIRAMATE TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 30, 2023 | NRA-ROSUVASTATIN TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 30, 2023 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2023 | MYLAN-FINGOLIMOD | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2023 | SANDOZ RABEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2023 | PRECEDEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2023 | METOJECT SUBCUTANEOUS | Medexus Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2023 | AG-ESCITALOPRAM TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2023 | VITRAKVI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2023 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 29, 2023 | FERRIPROX; FERRIPROX MR | Chiesi Canada Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2023 | RIVA-PERINDOPRIL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2023 | NAT-ANASTROZOLE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 29, 2023 | TEVA-DASATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2023 | MYLAN-TOPIRAMATE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2023 | FULVESTRANT INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 28, 2023 | FOCLIVIA | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2023 | ZIRABEV | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2023 | MVASI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2023 | COTELLIC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2023 | PAROXETINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 28, 2023 | M-ESCITALOPRAM | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2023 | NGENLA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2023 | SANDOZ LENALIDOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2023 | JAMP RABEPRAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2023 | ARSENIC TRIOXIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2023 | NOROMBY; NOROMBY HP | Juno Pharmaceuticals Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2023 | SANDOZ RABEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2023 | TEVA-LORAZEPAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2023 | APO-TOPIRAMATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2023 | CABENUVA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2023 | XOFLUZA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2023 | ACH-ANASTROZOLE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2023 | WELLBUTRIN XL | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2023 | NAPROXEN CAPSULES 200 MG | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2023 | MEDPRO DEFENSE NOCOLYSE | A.M.G. Medical Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2023 | SANDOZ MONTELUKAST | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2023 | NABUMETONE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 24, 2023 | ACH-TEMOZOLOMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2023 | TEVA-PANTOPRAZOLE MAGNESIUM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2023 | PMS-TOPIRAMATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2023 | COLUMVI | Hoffmann-La Roche Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 24, 2023 | OXALIPLATIN INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | APO-TERIFLUNOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | IPG-ANASTROZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | SANDOZ ANASTROZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | PMS-TERIFLUNOMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | JAMP LENALIDOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | AURO-DEFERASIROX (TYPE J) | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | APO-SUMATRIPTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | CALCIMAR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2023 | APO-KETOROLAC | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2023 | APO-ABIRATERONE FILM COATED TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | GALAFOLD | Amicus Therapeutics Uk Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2023 | SANDOZ BRIMONIDINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2023 | PURINETHOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2023 | TECARTUS | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2023 | TEVA-PANTOPRAZOLE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 22, 2023 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2023 | BUSPIRONE HYDROCHLORIDE TABLETS, USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2023 | DIOVAN | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2023 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2023 | NRA-EZETIMIBE TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 22, 2023 | NRA-METFORMIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 22, 2023 | PRO-AMOXI CLAV | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 22, 2023 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2023 | SPEVIGO | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · Priority-NAS |
| March 22, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 22, 2023 | TULISSIN 25 | Virbac Animal Health Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 21, 2023 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2023 | NETVISION | University Health Network | New Drug Submission (NDS) · Admin |
| March 21, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2023 | PERINDOPRIL ERBUMINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2023 | CITALOPRAM | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 21, 2023 | CASPOFUNGIN ACETATE FOR INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 21, 2023 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2023 | MEROPENEM FOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 21, 2023 | RIVA-DUTASTERIDE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2023 | RIVA-OMEPRAZOLE DR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2023 | JAMP DORZOLAMIDE-TIMOLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2023 | RIVA-GABAPENTIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2023 | GABAPENTIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2023 | DEXLANSOPRAZOLE | Altius Healthcare Inc | New Drug Submission (NDS) · Admin |
| March 21, 2023 | TARO-DILTIAZEM T | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 21, 2023 | TNKASE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2023 | AURO-CYCLOBENZAPRINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 20, 2023 | VENLAFAXINE XR | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 20, 2023 | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 20, 2023 | BIO-ESCITALOPRAM | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 20, 2023 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2023 | SUBOXONE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2023 | CERTICAN | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2023 | CISPLATIN INJECTION BP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 17, 2023 | AA-AMILZIDE | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2023 | FULVESTRANT INJECTION | Ever Valinject Gmbh | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2023 | PREVACID; PREVACID FASTAB | Takeda Pharmaceuticals America Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2023 | ALBRIOZA | Amylyx Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2023 | TEVA-AMBRISENTAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2023 | PRZ-DOXYCYCLINE | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2023 | NRA-OLANZAPINE ODT | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 16, 2023 | QINLOCK | Deciphera Pharmaceuticals. Llc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2023 | TULAJECT | Alivira Animal Health Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2023 | RIVA-CELECOX | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 16, 2023 | RIVA-ARIPIPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 16, 2023 | HYDROXYCHLOROQUINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 15, 2023 | MICRO+ TE PEDIATRIC | Sandoz Canada Inc. | New Drug Submission (NDS) · Other |
| March 15, 2023 | ATORVASTATIN-10; ATORVASTATIN-20; ATORVASTATIN-40; ATORVASTATIN-80 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2023 | ODAN CLOBETASOL SPRAY | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2023 | ADDERALL XR | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2023 | MELPHALAN FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2023 | SYNJARDY | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2023 | ISTODAX | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2023 | RIVA-OLANZAPINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 14, 2023 | PMS-CALCITRIOL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 14, 2023 | PANTOPRAZOLE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 14, 2023 | JAMP CEPHALEXIN SUSPENSION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2023 | AURO-ONDANSETRON INJECTION; ONDANSETRON INJECTION BP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2023 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2023 | CLOLAR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2023 | PMS-LOSARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 10, 2023 | APO-KETOROLAC INJECTABLE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2023 | ALHEMO | Novo Nordisk Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| March 10, 2023 | RIVA-ZOPICLONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 10, 2023 | APO-VENLAFAXINE XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 10, 2023 | RIVA-PREGABALIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 10, 2023 | JAMP-FLUCONAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 10, 2023 | EXTRA STRENGTH IBUPROFEN; IBUPROFEN CAPLETS; IBUPROFEN TABLETS | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 10, 2023 | TEVA-OLMESARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 10, 2023 | SUDAFED SINUS ADVANCE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 10, 2023 | IMIPENEM AND CILASTATIN FOR INJECTION, USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 10, 2023 | AMOXICILLIN/CLAV | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 10, 2023 | JAMP-AMOXICILLIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 10, 2023 | PACLITAXEL INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 10, 2023 | CANDESARTAN/HCTZ | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 9, 2023 | ENTOCORT | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | M-CLOPIDOGREL | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 9, 2023 | MAR-SERTRALINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 9, 2023 | CELECOXIB | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 9, 2023 | PMS-MEMANTINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2023 | BIVALIRUDIN FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2023 | OBIZUR | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | EVUSHELD | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | ANORO ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | FULPHILA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | KEPPRA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2023 | ACH-FESOTERODINE | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 9, 2023 | SEVOFLURANE | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2023 | MINT-ENTACAPONE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2023 | BIOESTROVET SWINE | Vetoquinol N A Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2023 | SIMVASTATIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2023 | MAR-SIMVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2023 | APO-ABACAVIR-LAMIVUDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2023 | TALTZ | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2023 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2023 | ELELYSO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2023 | AURO-LOSARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2023 | PRO-NAPROXEN EC | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2023 | MINT-CETIRIZINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2023 | KOVALTRY | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2023 | REMSIMA SC | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2023 | DILTIAZEM HYDROCHLORIDE INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 7, 2023 | FUROSEMIDE INJECTION, USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 7, 2023 | TARO-LOSARTAN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 7, 2023 | OCTREOTIDE INJECTION | Mont-Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 6, 2023 | SYMTUZA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2023 | PREZCOBIX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2023 | PREZISTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2023 | M-PANTOPRAZOLE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 6, 2023 | CELECOXIB | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 6, 2023 | DOXORUBICIN INJECTION, BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 6, 2023 | PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 6, 2023 | APO-METFORMIN ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 6, 2023 | OPTIGRID | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| March 3, 2023 | RETEVMO | Loxo Oncology Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | RIVA-FLUCONAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 3, 2023 | TARO-ANASTROZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2023 | TELMISARTAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 3, 2023 | PMS-LAMOTRIGINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2023 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | ROSUVASTATIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 3, 2023 | AURO-PAROXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2023 | FOSAVANCE | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | FOSAMAX | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | ATACAND PLUS | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | TIAZAC XC | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | DILANTIN INFATABS; DILANTIN-125 SUSPENSION; DILANTIN-30 SUSPENSION | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | DILANTIN | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2023 | CLAVASEPTIN 750 MG | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2023 | ROCURONIUM BROMIDE INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 2, 2023 | KYE-ESCITALOPRAM | Kye Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2023 | APO-LINEZOLID | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2023 | JAMP-AMOXICILLIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 2, 2023 | CALCITRIOL INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2023 | SANDOZ LOSARTAN HCT; SANDOZ LOSARTAN HCT DS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2023 | EVRYSDI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2023 | VYXEOS | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2023 | SPECTRAMAST LC | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2023 | AURO-CEFPROZIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2023 | CABAZITAXEL FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2023 | APO-GALANTAMINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2023 | DIOVAN-HCT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2023 | INVOKAMET XR | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2023 | NEURONTIN | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2023 | JAMP ATORVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 28, 2023 | MED-BRIMONIDINE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 28, 2023 | CITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 28, 2023 | RIVA-ATENOLOL | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 27, 2023 | PMS-COLCHICINE ER | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 27, 2023 | XOFLUZA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2023 | APO-METFORMIN ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2023 | CALQUENCE | Astrazeneca Canada Inc | New Drug Submission (NDS) · Other |
| February 24, 2023 | NEORAL; SANDIMMUNE I.V. | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2023 | PRZ-ATORVASTATIN | Pharmaris Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2023 | ACETAMINOPHEN INJECTION | B. Braun Melsungen Ag | New Drug Submission (NDS) · Other |
| February 24, 2023 | SANDOZ RISEDRONATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2023 | TEVA-BUPRENORPHINE/NALOXONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2023 | ESOMEPRAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2023 | TEVA-TELMISARTAN HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2023 | CYTOVENE | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2023 | NORVASC | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2023 | IPG-EZETIMIBE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2023 | NRA-MONTELUKAST | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 23, 2023 | SANDOZ DEFERASIROX | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2023 | URSO; URSO DS | Aptalis Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2023 | SANDOZ DEFERASIROX (TYPE J) | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2023 | JAMP IMATINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 22, 2023 | PMS-CYCLOBENZAPRINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2023 | FENTANYL CITRATE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | DOXORUBICIN HYDROCHLORIDE INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | CADUET | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2023 | SANDOZ VORICONAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | NAT-POMALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | NAT-POMALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | SANDOZ POMALIDOMIDE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2023 | POMALIDOMIDE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2023 | NAT-POMALIDOMIDE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2023 | MINT-LOSARTAN/HCTZ; MINT-LOSARTAN/HCTZ DS | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | JAMP-BRIMONIDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | APO-POMALIDOMIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2023 | NRA-PRAVASTATIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2023 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2023 | APO-SORAFENIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2023 | FERRLECIT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2023 | PMS-NIFEDIPINE ER | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | VANCOMYCIN HYDROCHLORIDE CAPSULES, USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | RBX-CLOPIDOGREL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | PMS-CLOPIDOGREL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | ACH-HYDROXYCHLOROQUINE SULFATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | PRO-OXAZEPAM | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| February 21, 2023 | AG-ZOPICLONE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 21, 2023 | JAMP-ZOPICLONE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 21, 2023 | NRA-FINASTERIDE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 21, 2023 | KETAMINE INJECTION, BP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 21, 2023 | PMSC-ATORVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | SANDOZ LOSARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | AURO-LOSARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2023 | AGRYLIN | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 21, 2023 | LEMICAM CHEWABLE TABLETS | Felix Pharmaceuticals Pvt. Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| February 20, 2023 | APO-LOSARTAN/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2023 | CABAZITAXEL FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2023 | REDDY-POMALIDOMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2023 | EFFEXOR XR | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2023 | APO-TOPIRAMATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2023 | TEVA-SIMVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2023 | REDDY-POMALIDOMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2023 | REDDY-POMALIDOMIDE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| February 17, 2023 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | VERITY-BCG | Verity Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | MED-EXEMESTANE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2023 | PMS-SERTRALINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2023 | DEFINITY | Lantheus Mi Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | SANDOZ MORPHINE SR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2023 | PALYNZIQ | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | CALCITONIN (SALMON) INJECTION, BP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 17, 2023 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | JAMP ROSUVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2023 | MENVEO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | METVIX | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | LORATADINE SOFT GEL CAPSULES | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2023 | SPIKEVAX BIVALENT | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | ALLERGY RELIEF 10 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2023 | VORICONAZOLE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2023 | AURO-VALGANCICLOVIR | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 16, 2023 | NRA-DONEPEZIL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2023 | AG-SITAGLIPTIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2023 | FROVATRIPTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2023 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | TIAZAC XC | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | ELLA | Laboratoire Hra Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | ZOLOFT | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | MEZAVANT | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | RESTASIS MULTIDOSE | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | REVALOR-XS | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2023 | JCOVDEN | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2023 | ODAN-FLUOXETINE | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2023 | FLUOXETINE | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Other |
| February 15, 2023 | APO-DIVALPROEX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 15, 2023 | SANDOZ CYCLOSPORINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2023 | TEVA-IMATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2023 | GLUMETZA; GLUMETZA (SB) | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2023 | VENOFER | American Regent, Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2023 | NUTROPIN AQ NUSPIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2023 | JAMP BUSPIRONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2023 | VIAGRA | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2023 | FROVA | Endo Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2023 | MAYZENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2023 | JAMP TOPIRAMATE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2023 | TEVA-BUDESONIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2023 | TEVA-LOSARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2023 | LEDAGA | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2023 | AZOPT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2023 | CELEBREX | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2023 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2023 | LIPITOR | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2023 | BUPIVACAINE HEAVY INJECTION BP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 9, 2023 | RENFLEXIS | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2023 | APO-ABACAVIR-LAMIVUDINE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 9, 2023 | RAYALDEE | Eirgen Pharma Limited | New Drug Submission (NDS) · Admin |
| February 9, 2023 | ORABLOC 1:100,000; ORABLOC 1:200,000 | Pierrel S.P.A. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 9, 2023 | CARBOPLATIN INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 9, 2023 | DIFLUCAN ONE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2023 | FLUCONAZOLE 150 | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2023 | IPG-CETIRIZINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | CARVYKTI | Janssen Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 9, 2023 | TELMISARTAN HCTZ | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 9, 2023 | DIFLUCAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2023 | INVANZ | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2023 | FLUCONAZOLE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | JAMP GABAPENTIN CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 9, 2023 | ACCEL-ONDANSETRON ODT | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 9, 2023 | MICAFUNGIN SODIUM FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | VALPROIC ACID; VALPROIC ACID ORAL SOLUTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | ESOMEPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | SANDOZ ROSUVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | APO-TICAGRELOR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | TARO-CLOBETASOL SPRAY | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2023 | CLADRIBINE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2023 | SANDOZ LINEZOLID | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2023 | MINT-INDOMETHACIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2023 | TEVA-VALACYCLOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2023 | APO-ANASTROZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2023 | CAMBIA | Aralez Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2023 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2023 | ALBRIOZA | Amylyx Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2023 | NEUPRO | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2023 | PMS-SITAGLIPTIN TARTRATE/METFORMIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 7, 2023 | ALEMBIC-LACOSAMIDE | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2023 | CLEVIPREX | Chiesi Farmaceutici S.P.A. | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2023 | TULINOVET | Modern Veterinary Therapeutics Llc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2023 | ZOPICLONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2023 | PANTOPRAZOLE MAGNESIUM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2023 | TARO-CELECOXIB | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2023 | AZACITIDINE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2023 | DEPAKENE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2023 | INTRALIPID 10%; INTRALIPID 20%; INTRALIPID 30% | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2023 | AURO-SERTRALINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 6, 2023 | JAMP-PANTOPRAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 6, 2023 | DULOXETINE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 6, 2023 | DESVENLAFAXINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 6, 2023 | TRISENOX | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2023 | MAR-TOPIRAMATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 6, 2023 | NALOXONE HYDROCHLORIDE INJECTION, USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 6, 2023 | M-SITAGLIPTIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 6, 2023 | APO-LEVOTHYROXINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 3, 2023 | MAR-CLOPIDOGREL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2023 | AG-QUETIAPINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2023 | ACETYLCYSTEINE INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2023 | M-METHOTREXATE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2023 | ADTRALZA | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2023 | BUPROPION HCL XL | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 3, 2023 | YUFLYMA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2023 | TIGECYCLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2023 | TARO-FENOFIBRATE E | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2023 | DANTRIUM CAPSULES | Endo Par Innovation Company, Llc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2023 | NRA-DULOXETINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2023 | PMS-RISEDRONATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2023 | MYLOTARG | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2023 | FLUCONAZOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 2, 2023 | RYBELSUS | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2023 | ACH-ROSUVASTATIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2023 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2023 | JAMP TEMOZOLOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2023 | PRO-NIFEDIPINE ER | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| February 2, 2023 | RUPALL | Medexus Inc | New Drug Submission (NDS) · Admin |
| February 2, 2023 | NRA-MIRTAZAPINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2023 | LIXIANA | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2023 | ROCURONIUM BROMIDE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 1, 2023 | SUPREFACT DEPOT 2 MONTHS; SUPREFACT DEPOT 3 MONTHS | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2023 | M-PRAVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 1, 2023 | M-ZOPICLONE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 1, 2023 | PYLERA | Laboratoires Juvise Pharmaceuticals | New Drug Submission (NDS) · Admin |
| February 1, 2023 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2023 | TARO-ROSUVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 1, 2023 | SANDOZ-DICLOFENAC; SANDOZ-DICLOFENAC SR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2023 | LEVULAN KERASTICK | Dusa Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2023 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 31, 2023 | AG-LATANOPROST | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 31, 2023 | JAMP CALCIUM POLYSTYRENE SULFONATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2023 | AURO-TELMISARTAN HCTZ | 31-Jan-2023 | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2023 | PMSC-VENLAFAXINE XR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 31, 2023 | MAR-TERIFLUNOMIDE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2023 | JEMPERLI | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 31, 2023 | PMS-CLONAZEPAM; PMS-CLONAZEPAM-R | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 31, 2023 | APO-ZOLPIDEM ODT | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2023 | MINT-IMATINIB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2023 | TEVA-TICAGRELOR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2023 | PMS-PERINDOPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2023 | JAMP QUETIAPINE FUMARATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2023 | AYBINTIO | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2023 | NAT-EVEROLIMUS | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2023 | AVALIDE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2023 | FLECAINIDE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 30, 2023 | SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 30, 2023 | PMS-VENLAFAXINE XR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 30, 2023 | ONCASPAR | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2023 | SUPRELORIN 4.7 MG IMPLANT | Virbac Ah, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2023 | KETOMED | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 27, 2023 | REPAGLINIDE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 27, 2023 | APO-TEMAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| January 27, 2023 | ARLIDIN | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| January 27, 2023 | ACH-LACOSAMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2023 | NEULEPTIL | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| January 27, 2023 | PRAMIPEXOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 27, 2023 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2023 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2023 | CEFEPIME FOR INJECTION, USP | Qilu Pharmaceutical Co. Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2023 | PENTACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2023 | QUADRACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2023 | JAMP-MYCOPHENOLATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2023 | AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2023 | BUTORPHANOL NASAL SPRAY | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2023 | JAMP GEFITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2023 | ZOLPIDEM TARTRATE ODT | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2023 | TREANDA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2023 | DETROL LA | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2023 | PRID DELTA | Ceva Animal Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | LETYBO | Croma Aesthetics Canada, Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | JAMP HYDROXYCHLOROQUINE SULFATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2023 | JAMP CLOBETASOL SPRAY | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 25, 2023 | PMS-ANASTROZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2023 | MAR-TRAMADOL/ACET | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 25, 2023 | OTIXAL | Medexus Inc | New Drug Submission (NDS) · Admin |
| January 25, 2023 | MINT-CLONIDINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 25, 2023 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2023 | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | Pierrel S.P.A. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 25, 2023 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | TELMISARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 25, 2023 | ARIPIPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 25, 2023 | XALACOM | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | XALATAN | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | DETROL | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | PHEBURANE | Medunik Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2023 | PRO-ZOPICLONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 24, 2023 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2023 | PMS-DICLOFENAC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2023 | REVOLADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2023 | GLASSIA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2023 | PRZ-METFORMIN | Pharmaris Canada Inc. | New Drug Submission (NDS) · Other |
| January 23, 2023 | DYSPORT AESTHETIC; DYSPORT THERAPEUTIC | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2023 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2023 | ANESKETIN | Eurovet Animal Health B V | Abbreviated New Drug Submission (ANDS) · Other |
| January 20, 2023 | TRODELVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2023 | KENGREXAL | Chiesi Farmaceutici S.P.A. | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 20, 2023 | EDURANT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2023 | MAR-LACOSAMIDE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2023 | JAMP ESCITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2023 | SANDOZ DILTIAZEM CD | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2023 | AURO-VENLAFAXINE XR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2023 | TEVA-CEFADROXIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2023 | PERINDOPRIL ERBUMINE/INDAPAMIDE; PERINDOPRIL ERBUMINE/INDAPAMIDE HD; PERINDOPRIL ERBUMINE/INDAPAMIDE LD | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| January 20, 2023 | APO-DONEPEZIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2023 | POLIVY | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2023 | COLD + SINUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2023 | MILRINONE LACTATE INJECTION USP | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2023 | IPG-SERTRALINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2023 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2023 | APO-MYCOPHENOLATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2023 | MAR-PANTOPRAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2023 | PRAXIS ASA EC 81 MG DAILY LOW DOSE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2023 | FLUCONAZOLE 150 | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| January 19, 2023 | MED-ROSUVASTATIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2023 | LINEZOLID INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2023 | MYLAN-LANSOPRAZOLE; MYLAN-LANSOPRAZOLE FDT | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2023 | COLD + SINUS PLUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2023 | PMS-ROSUVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | APO-ENTECAVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | MAR-DARUNAVIR | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | MED-DORZOLAMIDE-TIMOLOL | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | VARIVAX III | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2023 | PMS-FLUCONAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | MINT-HYDROXYCHLOROQUINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | AZACITIDINE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | SUMATRIPTAN INJECTION, USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 18, 2023 | JAMP-LOSARTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | ERTAPENEM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2023 | AA-ATENIDONE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2023 | APO-CITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2023 | AURO-TOPIRAMATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2023 | NAT-AZACITIDINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2023 | EQVALAN GOLD | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 16, 2023 | BIMZELX | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 16, 2023 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 16, 2023 | LEVETIRACETAM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 16, 2023 | PAROXETINE-10; PAROXETINE-20; PAROXETINE-30 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 16, 2023 | TEVA-CLOPIDOGREL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2023 | TRANEXAMIC ACID INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2023 | JAMP DICLOFENAC | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 16, 2023 | NAPROXEN MENSTRUAL PAIN RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2023 | APO-OLMESARTAN/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2023 | MINT-LACOSAMIDE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2023 | SANDOZ DUTASTERIDE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 13, 2023 | AYBINTIO | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2023 | TEVA-DICLOFENAC EC; TEVA-DICLOFENAC SR | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2023 | GLN-TOPIRAMATE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2023 | MED-DORZOLAMIDE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2023 | AURO-LAMIVUDINE/ZIDOVUDINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2023 | ARIPIPRAZOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 13, 2023 | MED-DUTASTERIDE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2023 | BOSULIF | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2023 | EVUSHELD | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2023 | ERTAPENEM FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2023 | TEVA-COMBO STERINEBS | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2023 | RIVA-PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 12, 2023 | TELMISARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 12, 2023 | AURO-DARUNAVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2023 | ERTAPENEM FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2023 | AURO-RAMIPRIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2023 | AURO-SIMVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2023 | ALTACE HCT | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2023 | XEOMIN, XEOMIN COSMETIC | Merz Pharmaceuticals Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2023 | TEVA-SITAGLIPTIN MALATE / METFORMIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2023 | PRO-CLONAZEPAM | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| January 11, 2023 | PRO-CLONAZEPAM | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| January 11, 2023 | PRO-DESVENLAFAXINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 11, 2023 | ZAROXOLYN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2023 | BORTEZOMIB FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2023 | PAROXETINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2023 | APO-DIMETHYL FUMARATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2023 | TARO-CLOPIDOGREL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 11, 2023 | MAR-CELECOXIB | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 11, 2023 | ZOMIG; ZOMIG NASAL SPRAY; ZOMIG RAPIMELT | Xediton Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| January 11, 2023 | XERMELO | Serb S.A. | New Drug Submission (NDS) · Admin |
| January 11, 2023 | PRO-SITAGLIPTIN MALATE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 11, 2023 | PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 11, 2023 | SANDOZ LETROZOLE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| January 11, 2023 | ZOLINZA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2023 | PMS-LOSARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2023 | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2023 | FLUCONAZOLE-150 | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2023 | MINT-LEVETIRACETAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 10, 2023 | AG-AMLODIPINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2023 | RUZURGI | Medunik Canada | New Drug Submission (NDS) · Priority-NAS |
| January 9, 2023 | APO-ABACAVIR-LAMIVUDINE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 9, 2023 | MUSCLE AND BACK PAIN PLATINUM RELIEF | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2023 | JAMP DIMETHYL FUMARATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2023 | APO-FLUTICASONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2023 | APO-FINGOLIMOD | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2023 | SANDOZ CLOBETASOL | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2023 | PMS-GABAPENTIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2023 | LINEZOLID INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2023 | KETOROLAC TROMETHAMINE INJECTION USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2023 | OCREVUS | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 6, 2023 | IPG-CLOPIDOGREL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 6, 2023 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 6, 2023 | PEGASYS | Zr Pharma& Gmbh | New Drug Submission (NDS) · Admin |
| January 6, 2023 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| January 6, 2023 | PRO-CIPROFLOXACIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 6, 2023 | APO-ENALAPRIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2023 | ZOPICLONE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 5, 2023 | JAMP-QUETIAPINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 5, 2023 | AZACITIDINE FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | JAMP-CLOPIDOGREL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | STELARA; STELARA I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2023 | HAIR REGROWTH FORMULA | Vita Health Products Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| January 5, 2023 | NABUMETONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | NIX CREME RINSE | Insight Pharmaceuticals LLC | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2023 | SANDOZ SITAGLIPTIN-METFORMIN XR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | SITAGLIPTIN-METFORMIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 5, 2023 | MIDAZOLAM INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | VIMPAT | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2023 | SITAGLIPTIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 5, 2023 | SANDOZ SITAGLIPTIN-METFORMIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | SITAGLIPTIN-METFORMIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 5, 2023 | RIVA SITAGLIPTIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 5, 2023 | TARO-SITAGLIPTIN FUMARATE | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | PMS-SITAGLIPTIN-METFORMIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | SANDOZ SITAGLIPTIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | JAMP SITAGLIPTIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | AURO-SITAGLIPTIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | SANDOZ SITAGLIPTIN-METFORMIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | SANDOZ SITAGLIPTIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | TEVA-SITAGLIPTIN MALATE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | PMS-SITAGLIPTIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | TEVA-SITAGLIPTIN MALATE / METFORMIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | PMS-SITAGLIPTIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2023 | ACH-SITAGLIPTIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2023 | ACH-SITAGLIPTIN | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 4, 2023 | VAXNEUVANCE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2023 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2023 | TRELEGY ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2023 | MYINFLA | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2023 | TARO-TRAMADOL ER | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2023 | SPRAVATO | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2023 | VENLAFAXINE XR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 4, 2023 | MAR-ESCITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 4, 2023 | AG-ACET-TRAMADOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 4, 2023 | RADICAVA | Mitsubishi Tanabe Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2023 | MINT-SIMVASTATIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2023 | DORZOLAMIDE-TIMOLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 3, 2023 | NEURONTIN | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2023 | VEGZELMA | Celltrion Healthcare Co Ltd | New Drug Submission (NDS) · Other |
| January 3, 2023 | AG-ANASTROZOLE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2023 | PMS-DICLOFENAC-MISOPROSTOL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 3, 2023 | LISINOPRIL/HCTZ (TYPE Z) | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |